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Abstract 
 
CBFβ is the non-DNA binding subunit of the core binding factors (CBFs). Mice 
with reduced CBFβ levels display profound, early defects in T but not B cell 
development. Here we show that CBFβ is also required at very early stages of natural 
killer (NK) cell development. We also demonstrate that T cell development aborts during 
specification, as the expression of Gata3 and Tcf7, which encode key regulators of T 
lineage specification, is substantially reduced, as are functional thymic progenitors. 
Constitutively active Notch or IL-7 signaling cannot restore T cell expansion or 
differentiation of CBFβ insufficient cells, nor can overexpression of Runx1 or CBFβ 
overcome a lack of Notch signaling. Therefore the ability of the prethymic cell to 
respond appropriately to Notch is dependent on CBFβ, and both signals converge to 
activate the T cell developmental program.  
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Introduction 
 
T cell development begins with colonization of the thymus by rare circulating 
bone marrow-derived progenitors 1, which expand to generate a population of early T 
lineage progenitors (ETPs). ETPs then give rise in an orderly fashion to cells expressing 
both CD4 and CD8 (DP) via several intermediate CD4/CD8 double negative (DN) 
stages (DN2, DN3 and DN4) 2. The earliest intrathymic stages of T lineage 
development, proliferation, and survival require signaling through Notch, c-kit, and the 
IL-7 receptor, plus the activity of several transcription factors including core binding 
factors (CBFs), Gata3, E2A, c-myb, Ikaros, TCF/LEF, and Ets family members 2. Notch 
and the CBFs were shown to interact genetically in other contexts, although their 
genetic hierarchy during T cell development is unknown.  
Natural killer (NK) cells develop in multiple sites including liver (fetal and adult), 
bone marrow, spleen, and thymus 3,4. The first NK lineage committed progenitors can 
be identified through their expression of the IL-2/IL15Rβ chain (CD122) and the 
absence of lineage-specific and mature NK cell markers 3. The differentiation of NKP 
into immature and mature NK cells is exquisitely dependent on IL-15 signaling 3. NK cell 
development does not require signaling through the c-kit receptor 3, and sustained 
Notch signaling inhibits NK cell differentiation 5-7. Transcription factors required for NK 
cell development include Ets-1, MEF, Id2, TCF/LEF, and members of the Ikaros family 
3
.  
CBFs are heterodimeric transcription factors consisting of a DNA binding subunit 
(Runx1, Runx2, or Runx3) and a non-DNA binding CBFβ subunit that increases the 
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affinity of the Runx subunits for DNA. Homozygous disruption of Runx1 results in a 
failure of hematopoietic stem cell (HSC) emergence in the conceptus 8, and in the adult 
Runx1 is required for megakaryocyte, B, and T cell development 9,10. Conditional 
deletion of Runx1 in bone marrow progenitors using Mx1-Cre blocked T cell 
development at the DN2 to DN3 transition 9,10, while deletion in DN3 cells with Lck-Cre 
modestly impaired the formation of DN4 and intermediate single positive cells 11. Runx1 
deletion in DP cells with Cd4-Cre reduced the number of mature CD4+ cells and 
eliminated a specialized subset of T cells with NK markers 11,12. However, an earlier, 
collective role for CBFs in T cell development was revealed by a hypomorphic Cbfb 
allele (Cbfbrss) that, when carried over a nonfunctional Cbfb allele caused an 85% 
reduction in CBFβ protein levels 13. Although HSCs emerged in Cbfbrss/- fetuses and B 
cells were generated, there was a profound defect in T cell development with what 
appeared to be consecutive partially penetrant blocks in the generation of ETPs, DN2, 
and DN3 cells, and an almost complete absence of DN4 and DP cells 13. 
Notch proteins (Notch 1-4) are transmembrane receptors, that upon binding the 
cell surface ligands Delta-like or Jagged, undergo two proteolytic cleavages to release 
the Notch intracellular domain (ICN) 14. ICN translocates into the nucleus, where it binds 
to the CSL/RBP-J (CBF1/RBP-J, Suppressor of Hairless, Lag-1) transcription factor, 
displacing corepressors and recruiting coactivators of the Mastermind-like (MAML) 
family. Disruption of Notch signaling either by conditional deletion of Notch1, by 
conditional deletion of CSL, or through expression of a truncated, dominant negative 
form of MAML1 completely blocks T cell development, and results in the generation of 
intrathymic B cells 14. Conversely, Notch is sufficient to drive T cell development, since 
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overexpression of a constitutively active form of Notch (ICN) leads to T cell at the 
expense of B cell development at extrathymic sites 14. Exposure of hematopoietic 
progenitors to plate- or cell-bound Notch ligands of the Delta-like family can drive T 
lineage development in culture 14-16. 
In two well-characterized examples in hematopoiesis Notch signaling was shown 
to function genetically upstream of the CBFs. Inactivation of Notch or its ligand Serrate 
in Drosophila caused the loss of Lozenge (a Runx homologue) expression in hemocyte 
progenitors 17, and mutations in Notch, Serrate, or Lozenge itself resulted in a failure to 
generate the subset of hemocytes called crystal cells 17,18. In mice, both Notch1 
signaling and Runx1 are required for hematopoietic cell emergence from the 
aorta/gonad/mesonephros (AGM) region 8,19-22. Notch1 signaling defects in mice and 
zebrafish impair Runx1 expression in the AGM region 19,20,23, and overexpression of 
Runx1 in Notch signaling mutants can rescue the emergence of hematopoietic cells 
from the AGM region, demonstrating that Runx1 is, at least in part, genetically 
downstream of Notch signaling 23,24.  
Here we characterized the molecular mechanism underlying the T cell defect 
caused by insufficient CBFβ levels. We show that T cell specification does not occur, as 
its multiple early markers (Gata3, Tcf7, Cd3e) fail to be expressed. Notch signaling is 
not impaired, and although IL-7 signaling is decreased, it is not solely responsible for 
the T cell defect. Finally, we show that reduced CBF levels cause an early and profound 
block in NK cell development, which is the first demonstration that the CBFs play an 
essential role in the NK cell lineage. 
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Materials and Methods 
Mice 
Generation and genotyping of the Cbfbrss (Cbfbtm2.1Spe) and Cbfb- (Cbfbtm1Spe) 
alleles were described previously 13,25.  The animal protocols used in these studies were 
approved by our Institutional Animal Care and Use Committees. 
 
Transplant analyses 
C57BL/6 (B6.SJL-Ptprc<a>Pep3/BoyJ) x 129S1/SVImJ F1 mice (Ly5.1+/Ly5.2+) 
were subjected to two split doses of 550 Rads 3-4 hours apart. Each recipient 
received donor fetal liver (FL) and competitor bone marrow (BM) cells (2 X 10 5 
cells of each) via tail vein injection. All donor fetuses were of a mixed C57BL/6J 
and 129S1/SVImJ background and expressed the Ly5.2 (CD45.2) haplotype. 
Whole BM competitor cells were prepared from C57BL/6 (B6.SJL-
Ptprc<a>Pep3/BoyJ) (Ly5.1+) mice.  
 
Flow cytometry and cell sorting 
Flow cytometric analyses were performed on a dual-laser FACSCalibur, 
FACSCanto, or on a four-laser LSRII (BD Biosciences). The following antibodies 
were purchased from PharMingen (San Diego, CA), Ebiosciences (San Diego, CA) 
or Biolegend (San Diego, CA): CD3ε (145-2C11), CD4 (RM4-5), CD8α (53-6.7), 
CD11b (M1/70), CD11c (HL3), CD19 (1D3), CD25 (7D4), CD27 (LG.7F9), CD44 (IM7), 
CD45 (30-F11), B220 (RA3-6B2), Gr-1 (RB6-8C5), CD127/IL-7Rα (A7R34), TCRβ 
(H57-597), TCRγ (GL3), NK1.1 (PK136), CD49b (DX5), CD122 (TM-b1), CD132 (4G3), 
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NKG2D (CX5), CD45.1 (A20), CD45.2 (104), Thy1.2 (53.2.1), c-kit (2B8), and pStat5 
(47). On the LSRII platform, doublets were excluded through their FSC-W and 
SSC-W characteristics and DAPI was used for dead cell exclusion. The data were 
analyzed using FlowJo (version 6.1.1, Tree Star, San Carlos, CA). Cells were 
sorted on a FACSAria (BD Biosciences).  
 
Cell cycle analysis 
Fetal thymocytes (17.5 dpc) were stained with FITC conjugated antibodies 
(CD8, TCRβ, TCRγ, CD11b, Ter119, B220) and subsequently cultured in DMEM 
with 10% FBS and pulsed with BrdU (BD Bioscience) for one hour. Cells were 
harvested and stained with anti-BrdU APC, CD45 PerCP-Cy5.5 and 7-AAD. 
 
In vitro IL-7 stimulation and intracellular staining for TCRβ, TCRγ, and pStat5 
Fetal thymocytes (17.5 dpc) were stained with FITC conjugated lineage 
antibodies (CD8, CD3, TCRβ, TCRγ, CD11c, B220, NK1.1, Mac1, Ter119) as 
described elsewhere 26,27. Thymocytes were then incubated at 37°C for 20 min in 
DMEM (Invitrogen, Carlsbad, CA) with 10% FBS, then treated with 0, 1, and 5 
ng/ml IL-7 for an additional 20 min. At the end of the stimulation, cells were 
immediately fixed with 1.6% formaldehyde at room temperature for 10 minutes, 
and permeabilized in ice-old methanol for 20 minutes. Cells were stained with PE-
conjugated anti-phospho-STAT-5 (Tyr694) plus antibodies to CD44, CD25, and 
CD45. The analysis of intracellular TCR staining was performed using the same 
protocol minus the incubation and cytokine stimulation. 
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Enrichment of FL progenitors and OP9 co-cultures 
Lineage negative (Lin-) FL cells (E14.5–E17.5) were isolated by depletion of 
Lin+ (CD19, Gr1, Ter119, F4/80) cells using MACS LS columns (Miltenyi Biotech, 
Auburn, CA). An anti-IL-7Rα biotin labeled antibody was included in the lineage 
cocktail in experiments in which Notch signaling was inhibited by GSI.  
OP9 and OP9-DL1 cells 16 were cultured in Minimum Essential Medium 
Alpha supplemented with 20% FBS (Invitrogen). Co-cultures were performed in 
24-well plates by adding 1-5 × 105 Lin- cells to confluent OP9-DL1 monolayers 
along with 5 ng/mL human Flt3L and 1 ng/mL murine IL-7 (PeproTech, Rocky Hill, 
NJ). IL-6 (1 ng/ml) and 25 ng/ml IL-15 were included in the cultures to enhance the 
generation of T, B and NK cells. Various concentrations of γ-Secretase Inhibitor X 
(GSI) (InSolutionTM, EMD Biosciences, San Diego, CA) in DMSO were added to the 
cultured cells. Co-cultured cells were harvested and analyzed weekly unless 
otherwise indicated.  
 
Retroviral infection of hematopoietic progenitors 
cDNAs encoding Runx1 (AML1b), the CBFβ heterodimerization domain (aa 
1-141), full length CBFβ, Stat5a, and Stat5aF were subcloned into the bicistronic 
MigR1 retrovirus 28. MigR1 expressing the Notch ICN was previously described 29. 
Retroviruses were produced in Phoenix cells. One milliliter of viral supernatant, 
polybrene (2 ng/ml) and cytokines (IL-7 and Flt3L) were added to overnight co-
cultures of Lin- FL cells or thymocytes on OP9-DL1 in 24-well plates and 
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spinoculated at 1400 g at room temperature for 2 hours. The media was changed 
24 hours post spinoculation and the co-culture continued as described above. 
 
Quantitative RT-PCR 
Total RNA was extracted from sorted or unsorted cells using the RNeasy 
Mini Kit and DNase I treatment (Qiagen, Valencia CA). RNA quality was assessed 
on agarose gels and quantified by Nano-Drop1000 (Nano-Drop, Wilmington, DE). 
First strand cDNA was generated using reverse transcriptase SuperscriptIII 
(Invitrogen) and oligo (dT)20 primers. Real-time PCR was performed in triplicate 
on Applied Biosystems' 7500 Real-Time PCR System (Foster City, CA). Either 
Taqman probes or SYBR-Green (Applied Biosystems) were used to detect gene 
expression. The following pre-made mixture of primers and Taqman probes were 
used: Runx1 (Mm00486762_m1); Runx3 (Mm00490666_m1); Cbfb 
(Mm00491551_m1); Jak1 (Mm00600614_m1); Jak3 (Mm00439962_m1); Stat3 
(Mm00456961_m1); Stat5a (Mm00839861_m1); Stat5b (Mm00839861_m1); Hprt1 
(Mm00446968_m1).  
The following primers were used for SYBR Green detection: Dtx1   
For TGAGGATGTGGTTCGGAGGT, Rev CCCTCATAGCCAGATGCTGTG; Hprt 
For CTCCTCAGACCGCTTTTTGC, Rev TAACCTGGTTCATCATCGCTAATC; Notch1 
For CAGCTTGCACAACCAGACAGAC, Rev ACGGAGTACGGCCCATGTT. Primers 
for Pu.1, Cd3g and Cd3e were described previously 30,31. Absolute quantification 
of each gene was calculated by the standard curve method using 10-fold dilutions 
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of a positive control (spleen cell cDNA). Expression of individual genes was 
normalized to Hprt expression. 
 
Western blot analysis 
GFP+ cells were sorted from OP9-DL1 co-cultures (purity >99.9%) and 
resuspended at 1x 105 cells per ml in lysis buffer (150 mM NaCl, 50 mM Tris, pH 
8.0, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 0.2 mM EDTA, 2.0 mM EGTA 
plus 1 µg/ml pepstatin A, 1 µM Pefablock, 2 µg/ml leupeptin, 2 µg/ml aprotinin). 
Lysates were boiled in SDS loading buffer, resolved by SDS-PAGE through 4 - 
12% Bis-Tris gels (Invitrogen), proteins transferred to nitrocellulose and the blot 
probed with a mouse monoclonal antibody to CBFβ (β141.2) 25. The blots were 
developed with ECL reagents (Pico kit, Pierce, Rockford, IL).  
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Results 
 
The T cell defect exhibited by Cbfbrss/- cells is recapitulated ex vivo. 
We previously assessed the collective role of core binding factors in 
hematopoiesis by using a hypomorphic allele of the common non-DNA binding 
CBFβ subunit gene (Cbfbrss). Cbfbrss/- fetal liver (FL) cells (expressing 
approximately 15% of normal CBFβ levels) contained HSCs that could contribute 
to the formation of myelo-erythroid and B lineage cells, but not to DN4 or DP T 
cells13. To further investigate the molecular basis of this defect, we cultured Lin- 
FL progenitors from 14.5 – 17.5 days post coitus (dpc) mice on OP9 stromal cells 
expressing the Notch ligand Delta-like1 (OP9-DL1 cells) to induce T cell 
differentiation ex vivo 16. Within two weeks after establishing the OP9-DL1 co-
cultures, Cbfb+/+ progenitors underwent extensive proliferation (Fig 1A,B), and 
approximately half became CD4/CD8 double positive (DP) (Fig 1C,D) and gave 
rise to clear populations of TCRβ+ (not shown) and TCRγ+ cells (Fig 1E,F). In 
contrast, the in vitro expansion of Cbfbrss/- cells was significantly depressed (Fig 
1A,B). Cbfbrss/- progenitors generated very few DP cells (Fig 1C,D), TCRγ+ cells 
(Fig 1E,F), or TCRβ+ cells (not shown), and the DN cells contained no detectable 
intracellular TCRβ (Fig 1G).  Cbfbrss/rss Lin- FL cells, which have higher CBFβ 
levels than Cbfbrss/- cells 13, also produced fewer cells and a significantly smaller 
percentage of TCRγ+ cells (Fig 1B,F), however the defects were not as 
pronounced as those of Cbfbrss/- cells, indicating that T cell development was 
affected in a dose dependent manner ex vivo.  
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Cbfbrss/- cells fail to undergo T lineage specification 
We examined the DN populations to more precisely define the T cell 
developmental defect caused by reduced CBFβ dosage. Following seven days of 
culture on OP9-DL1, most Cbfb+/+ Lin- FL cells had progressed to the DN2 and 
DN3 stages, whilst the majority of Cbfbrss/- cells were arrested prior to the DN2 
stage (Fig 2A,B). Thymocytes from 16.5-17.5 dpc Cbfbrss/- fetuses also exhibited 
an early T cell developmental arrest, but a higher percentage of thymocytes 
appeared to progress to the DN2 and DN3 stages (Fig 2C,D). We suspect that the 
lower numbers of phenotypic DN2 and DN3 cells generated ex vivo may be 
caused by differences in the quality or intensity of signaling provided by OP9-DL1 
cells as compared to thymic stromal cells.  
We examined Cbfbrss/- DN cells for molecular markers of T cell 
differentiation. Thy1.2+ DN1 thymocytes were present in Cbfbrss/- 17.5 dpc fetuses, 
but in significantly reduced numbers (Fig 2E). Cbfbrss/- DN thymocytes contained 
no intracellular TCRβ or TCRγ chains, which are normally found in DN3 and DN4 
cells, respectively 32, indicating that development arrested before the commitment 
stage  (Fig 2F). The ex vivo defect was more pronounced, as Thy1.2+ cells were 
absent in the DN1 population (Fig 2E), although most thymocytes that progressed 
to the DN2 stage did express Thy1.2 (Fig 2G). Cd3e expression, which can 
normally be found in both DN1 and DN2 cells 33 was essentially undetectable in 
Cbfbrss/- DN2 cells purified from the OP9-DL1 cultures, and Cd3g mRNA levels 
were significantly reduced (Fig 2H). Gata3 and Tcf7 expression progressively 
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increased in wild type DN1 (Fig 2I) and DN2 (not shown) cells over a five-day 
culture period 30, but remained low and unchanged in Cbfbrss/- DN1 and DN2 cells. 
PU.1 expression was not elevated in the Cbfbrss/- DN1 population, suggesting re-
specification into myeloid lineage cells had not occurred 30.  
To determine whether Cbfbrss/- fetuses contained functional thymic 
progenitors, we attempted to rescue T cell development by reintroducing CBFβ 
into Cbfbrss/- thymocytes. Although we could successfully rescue the formation of 
DP, TCRγ+, and DN2-DN4 cells following retroviral transduction of CBFβ into Lin- 
Cbfbrss/- FL progenitors (Fig 2J,K), we could not efficiently rescue T cell 
development from Cbfbrss/- fetal thymocytes (Fig 2L). We could transduce wild 
type thymocytes with GFP-expressing retroviruses and recover GFP+CD45+ and 
GFP+DP cells, thus our retroviral transductions were effective. However, we could 
recover only very few GFP+CD45+ cells from Cbfbrss/- thymocytes transduced with 
a bicistronic virus expressing both CBFβ  and GFP, although these included DP 
cells (Fig 2L). Cbfbrss/- DN thymocytes were actively cycling (Fig 2M,N), thus it is 
unlikely that our failure to rescue T cell development is due to a lack of cells 
permissive for retroviral transduction. We conclude that Cbfbrss/- thymi contain 
very few functional T cell progenitors. Altogether, these data indicate that Cbfbrss/- 
cells have a global, early defect in T cell specification.  
 
IL-7 signaling and c-kit expression in Cbfbrss/- cells 
We determined if CBFβ insufficiency affected the expression or activity of 
one or more signaling pathways required at early stages of T cell development. 
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IL-7 signaling is essential at the DN1 and DN2 stages, and cell surface IL-7Rα 
levels become elevated at the DN2 stage 34-38. CBFs directly activate the Il7ra (IL-
7Rα) gene at later stages of T cell differentiation, in DP and CD4+ cells 11,39. We 
found that the mean fluorescence intensity (MFI) of IL-7Rα (CD127) staining was 
comparable in Cbfb+/+ and Cbfbrss/- DN2 thymocytes, and that of the common 
gamma chain (γc/IL2RG/CD132) was approximately 2.5 fold higher (Fig 3A). 
However, the levels of mRNAs encoding several IL-7 signaling molecules, 
including Jak1, Stat5a, and Stat5b, were significantly (~2 fold) lower in Cbfbrss/- 
DN2 cells (Fig 3B) and intracellular pStat5 levels were decreased by ~7 fold (Fig 
3C). Decreased JAK/STAT signaling, though, cannot be solely responsible for the 
T cell expansion or differentiation defects, as neither could be reversed upon 
expressing a wild type or constitutively active form of Stat5a 40 (Fig 3D).  
c-kit signaling is also critical for the proliferation and differentiation of DN1 
and DN2 cells 38,41. We found that neither the percentage of c-kit+ DN1 
thymocytes, nor the MFI of c-kit staining was altered in Cbfbrss/- fetuses (Fig 3E). 
The percentage of c-kit+ cells and staining intensity was also similar in Cbfb+/+ 
and Cbfbrss/- DN1 cells derived from OP9-DL1 cultures (Fig 3F). Therefore the T 
cell defect does not appear to be caused by reduced cell surface c-kit expression, 
although deficiencies in c-kit signaling were not examined and cannot be ruled 
out. 
 
Notch signaling is active in Cbfbrss/- cells 
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To examine the ability of Cbfbrss/- progenitors to receive Notch signals, we 
purified the DN1 population from OP9-DL1 co-cultures at days 3, 4 and 5, and 
quantified the expression of Notch1 and several of its target genes by qRT-PCR 
(Fig 4A). Notch1 was expressed in Cbfbrss/- cells at all time points examined, 
although its levels were reduced approximately 2 fold in freshly isolated “DN1”  
(i.e. Lin- CD45+ CD44+CD25-) FL cells (day 0) and in DN1 cells isolated after three 
days of culture on OP9-DL1 cells, and slightly more than two fold at days 4 and 5 
of culture. Expression of the Notch1 target genes Hes1 and Hes5 were reduced ≤ 
2-fold in Cbfbrss/- `DN1 cells at all time points examined (Fig 4A). Deltex1 (Dtx1) 
expression is known to be a very sensitive indicator of Notch signaling 42-44, and 
was reduced almost 10 fold in Cbfbrss/- DN1 cells by days 4 and 5 of culture. 
Although this is a substantial decrease, Dtx1 levels did in fact increase in Cbfbrss/- 
DN1 cells approximately 100-fold during the culture period. Thus, although there 
were significant reductions in the expression of Notch1 and several of its target 
genes, the fact that their expression was not completely absent and was 
significantly induced after exposure to Notch ligands suggested that Notch 
signaling was active in Cbfbrss/- cells. Differences in the initial composition of the 
DN1 population that could change further over the culture period could account 
for the relative decreases in the levels of Notch1 and its targets, due to 
enrichment of the Cbfb+/+ (but not the Cbfbrss/-) DN1 population for T lineage-
specified cells. 
To determine if Notch signaling was functionally intact, we treated OP9-DL1 
co-cultures with a γ-secretase inhibitor (GSI) to block Notch signaling. When 
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Notch signaling is blocked in wild type progenitors, B cells will develop at the 
expense of T cells 45,46. Since OP9-DL1 co-cultures of Cbfbrss/- Lin- cells did not 
contain CD19+ B cells (Fig 4B), nor were B cells detected in thymi of mice 
transplanted with Cbfbrss/- FL cells 13, this suggested that Notch signaling was 
actively repressing B cell development. As expected, inhibition of Notch signaling 
with 1 µM and 3 µM GSI resulted in the differentiation of CD19+ B cells from 
Cbfb+/+ Lin- cells (Fig 4B). GSI even more efficiently induced the formation of B 
cells from Cbfbrss/- Lin- cells, confirming that Notch1 signaling was sufficiently 
active in Cbfbrss/- cells to repress B cell fate (Fig 4B). An increase in NK1.1+ NK 
cells was also observed in Cbfb+/+ co-cultures treated with GSI, but not in Cbfbrss/- 
co-cultures. Thus Cbfbrss/- cells had a defect in NK cell development, which will be 
discussed in more detail later. 
Although Notch signaling in Cbfbrss/- cells was adequate to suppress B cell 
development, higher levels of Notch signaling are required to drive T cell 
development 7. Therefore to confirm that the lower levels of Notch1, or other 
defects in Notch signaling were not the underlying cause of the T cell 
developmental defect, we transduced Cbfbrss/- Lin- FL cells with a retrovirus 
expressing the constitutively active intracellular form of Notch1 (ICN). Cbfb+/+ 
cells expressing high levels of ICN (based on the surrogate GFP marker) 
efficiently differentiated into DN2 and DN3 cells following seven days of culture 
on OP9 cells (Fig 4C). On the other hand, Cbfbrss/- progenitors expressing ICN 
grew poorly, giving rise to a low percentage of GFP+ cells (1.7% ± 0.5% versus 
66.6% ± 15.0% for Cbfb+/+ cells), and only a few of those cells differentiated to and 
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past the DN2 stage (Fig 4D). Thus, constitutively high levels of Notch signaling 
did not rescue T cell development, but instead selected against the growth or 
survival of Cbfbrss/- cells. Since high levels of Notch signaling efficiently block B 
and NK cell development 47, and T cell development from Cbfbrss/- progenitors 
could not be rescued by ICN, the ICN-expressing Cbfbrss/- cells could not 
differentiate into the T, NK or B cell lineages, and appeared to be selected 
against, thus yielding relatively few GFP+ cells in the cultures. Therefore the 
moderate decrease in Notch1 expression, or potential defects in ligand binding or 
cleavage of the Notch receptor are unlikely to be responsible for the Cbfbrss/- early 
T cell defect but in fact may be selectively enriched to permit survival of the 
Cbfbrss/- cells. 
 
Runx1, Runx3, and CBFβ expression are not dependent upon Notch signaling. 
Runx1 expression is activated by Notch signaling during hematopoietic 
stem cell development 19,20,23,24, thus we determined whether Runx1, Runx3, or 
Cbfb expression in T cells also required Notch signaling. Addition of 1 µM and 3 
µM GSI to Cbfb+/+ OP9-DL1 co-cultures impaired the differentiation of DN2 and 
DN3 cells in a dose dependent manner (Fig 5A). Expression of the Notch1 targets 
Hes1 and Dtx1 was significantly decreased in DN1 cells, as was Gata3 and Tcf7 
(Fig 5B), demonstrating that Notch signaling and T cell development were indeed 
inhibited at the 3 µM GSI concentration. However, Runx1, Runx3, and Cbfb 
expression did not significantly change in DN1 cells in the presence of GSI, 
consistent with the conclusion that none of these genes are downstream 
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activated targets of Notch1 in early T lineage progenitors (Fig 5B).  Since 
heterogeneity of the DN1 population could obscure modest changes in gene 
expression, we purified c-kit+CD27+CD25- lymphoid progenitors from the DN1 
population 30 and assessed Runx1 expression (Fig 5C). Inhibition of Notch 
signaling with 3 µM GSI resulted in a small but significant increase in Runx1 
mRNA levels in c-kit+CD27+CD25- cells, confirming that Runx1 expression in 
lymphoid progenitors does not require Notch signaling. Moreover, retroviral 
overexpression of neither Runx1 (Fig 5D) nor CBFβ (not shown) in Cbfb+/+ 
progenitors treated with 3 µM GSI could rescue the perturbation in T cell 
development caused by inhibition of Notch signaling, supporting the hypothesis 
that blocking Notch signaling does not impair T cell development by affecting 
Runx1, Runx3, or Cbfb expression.  In summary, the activity of the Notch pathway 
does not depend on the CBFs, nor does CBF expression require Notch activity. 
Rather, Notch and CBF expression and activity are independently regulated in 
uncommitted thymic progenitors, and converge to specify the T cell lineage. 
  
CBFβ is required for NK cell development 
 Although Cbfbrss/- Lin- cells were capable of producing B cells, we 
observed a defect in NK cell development when Notch signaling was inhibited 
(Fig 4B). We examined this more directly by culturing Lin- FL cells on OP9 stromal 
cells in the presence of Flt3L, IL-7, and IL-15. CD122 (IL2Rβ) is a subunit of the IL-
15 receptor and is regulated by the CBFs 48. Cbfb+/+ Lin- FL cells generated a large 
number of CD122+ cells, including NK1.1+ CD122+ NK cells and NK1.1- CD122+ NK 
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progenitors (NKP). Cbfbrss/- Lin- FL cells, on the other hand, produced very few 
CD122+ cells (Fig 6A,B) that would be capable of responding to IL-15 signaling. 
These data indicate that ex vivo NK cell development from fetal liver cells was 
blocked very early, prior to the NKP stage.  
To assess whether there was also an in vivo NK cell defect, we examined 
thymuses from 15.5 dpc Cbfbrss/- fetuses for NK cells. Bipotent T/NK progenitors 
and mature NK cells in the fetal thymus both express NK1.1 49. Cbfbrss/- fetal 
thymuses contained very few NK1.1+ (or NK1.1+ CD122+) cells (Fig 6C,D), 
indicating that almost no mature NK cells or bipotent T/NK progenitors were 
present. We also examined mice transplanted with Cbfb+/+, Cbfbrss/rss, and Cbfbrss/- 
17.5 dpc FL cells 13 for the presence of donor-derived NK cells. As expected, there 
were no or very few donor-derived T cells in the bone marrow or spleen of mice 
transplanted with Cbfbrss/- FL cells (Fig 6E,F). Donor-derived mature NK cells were 
present in the peripheral blood (not shown), bone marrow (Fig 6E), spleen (Fig 
6F) and thymus (not shown) of transplant recipients of Cbfb+/+ and Cbfbrss/rss FL 
cells. However Cbfbrss/- donor-derived mature and immature NK cells (NK and 
iNK) were completely absent in recipients reconstituted with Cbfbrss/- FL cells (Fig 
6E,F). We also observed a decreased contribution of Cbfbrss/- FL cells to CD19+ B 
cells in the bone marrow, but this decrease was not observed in the spleen, 
suggesting peripheral compensation for a partial defect in bone marrow B cell 
development (Fig 6E,F). The precipitous decline in NK cell development that 
occurred when the CBFβ concentration dropped from 30% (Cbfbrss/rss) to 15% 
(Cbfbrss/-) of normal levels mirrored the abrupt and profound T cell defects we 
 only.
For personal use at CALIFORNIA INST TECH/MILLIKAN LIBRARY on April 5, 2008. www.bloodjournal.orgFrom 
                                 
 20
observed at this same transition 13, indicating that both early T and NK cell 
development require a similar threshold level of CBFβ. We also examined the 
transplant recipients for committed NKP (Fig 6G). The percentage of donor-
derived NK cells and their precursors in both bone marrow and spleen of the 
transplant recipients was lower than in the C57BL/6 (B6) control, perhaps 
because of the more advanced age of the transplant recipients. This precluded 
evaluation of donor-derived NKP in the bone marrow, however we were able to 
detect NKP in the spleen. Mice transplanted with Cbfb+/+, Cbfbrss/rss, and Cbfbrss/- 
FL cells all contained a detectable population of NKP in their spleen (Fig 6G). 
Therefore the NK cell deficiency in transplanted adult mice occurred at the NKP 
to iNK transition, whereas in the fetal liver and thymus it preceded the emergence 
of NKP.  
We (and others) examined the expression of core binding factor genes in 
iNK and NK cells purified from wild type mice to ascertain which members of the 
Runx family might be required in NK cells 48. Runx1, Runx3, and Cbfb mRNA were 
all found in Lin-Sca-1+c-kit+ bone marrow progenitors, iNK, and NK cells, and both 
Runx3 and Cbfb mRNA levels increased during NK cell differentiation (Fig 6H). 
Runx2 mRNA levels were very low in Lin-Sca-1+c-kit+, iNK, and NK cells (not 
shown). Based on expression levels we predict that Runx1 and/or Runx3 are the 
Runx subunits most likely to be involved in NK cell development. 
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Discussion 
The CBFs and Notch cooperate in early T cell development 
We endeavored to define the molecular mechanisms underlying the 
requirement for CBFs in early T cell development by examining the expression of 
T cell specific genes, and signaling pathways important for T cell development in 
mice with reduced CBFβ levels. A small percentage of Cbfbrss/- cells reached the 
DP stage of T cell development when cultured on OP9-DL1 stromal cells, 
although the absolute number of cells that progressed past the DN1 stage was 
extremely low. The vast majority of Cbfbrss/- cells expressed very little if any Cd3e, 
Gata3, or Tcf7 mRNA, and no intracellular TCRγ or TCRβ chains were present. 
Thus, Cbfbrss/- cells lacked some of the earliest and most critical mediators of T-
lineage development, indicating that T-lineage specification had essentially failed 
to occur. Although Cbfbrss/- cells were competent to receive Notch signals and by 
virtue of that were restrained in their ability to undergo B cell development, they 
could not integrate the Notch signal in order to fully activate the T lineage 
program. Thus CBFs are needed to establish a T-lineage inducible state that is 
competent to respond to Notch signaling.  
The mechanisms by which the CBFs and Notch signaling converge to specify 
T cells are unknown. One possibility is that they integrate at the level of common 
target genes in ETPs and at subsequent stages of DN thymocyte development. A 
few bona fide direct Notch targets are known in mammals, the best examples of 
which are the Hairy/Enhancer of SPLIT (HES) genes 50. Although no HES genes 
have been implicated as direct CBF targets, the mammalian HES-1 protein has 
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been shown to physically interact with both Runx1 and Runx2, and HES-1 can 
potentiate Runx2 transactivation in reporter assays 51. Thus one mechanism by 
which Notch and CBFs may integrate their function is through the direct 
interaction of Runx and HES proteins. Genes such as Il2ra that encodes the CD25 
molecule could be directly and coordinately regulated by Notch and the CBFs 
39,43,52
.  
Our observations during T cell development contrast with the initial stages of 
hematopoiesis in vertebrates, where Runx1 expression is dependent upon 
Notch1 signaling (Fig 7), and overexpression of the mammalian or zebrafish 
Runx1 protein could rescue hematopoiesis from the AGM region in Notch mutant 
animals 19,20,23,24,53. In contrast, neither Runx1 nor CBFβ expression was 
decreased, nor could overexpression of Runx1 nor CBFβ restore T cell 
development when Notch signaling was inhibited. 
 
Defects in both early T and NK cell development implicate pathways essential for 
both lineages 
Although we could restore T cell development when we overexpressed 
CBFβ in Cbfbrss/- Lin- FL cells, we were unable to efficiently restore proliferation or 
T cell differentiation from Cbfbrss/- thymocytes. One possible explanation for this 
failure is that the defect may originate in a prethymic T cell progenitor, and as a 
result very few of them emigrate to the thymus, or they fail to proliferate or 
survive once they arrive. The majority of T cell progenitors in the fetal liver and 
thymus have both T and NK cell potential 54-58, and a defect within this population 
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could also account for the lack of NK cells we observed in OP9 cultures of fetal 
liver cells, and in the fetal thymus. Both the T and NK cell defects became 
pronounced when CBFβ levels were reduced from 30% to 15% of normal levels, 
consistent with the hypothesis that they be ultimately traced, in part, to 
perturbations in the expression of genes required in both lineages, or to a 
common progenitor. Preliminary data indeed suggest that 12.5 dpc Cbfbrss/- fetal 
livers contained 6 to 7-fold fewer phenotypic (c-kit+ CD127+ PIR-A+) trilineage T, 
NK, and dendritic cell  (T/NK/DC) progenitors 55 (not shown). Furthermore, fetal 
thymuses contained only very low numbers of NK1.1+ cells, which include all the 
bipotent T/NK progenitors and mature NK cells 49. The small number of Cbfbrss/- 
T/NK progenitors that do colonize the thymus may, in addition, be functionally 
defective, perhaps because they have undergone irreversible epigenetic changes, 
or were unresponsive to the cytokines (Flt3L and IL-7) that we used in the 
transduction cocktail.  
 The NK cell defect in the transplanted adult mouse appeared to occur 
somewhat later, at the transition between NKP and iNK cells. NKP differentiate 
from the HSC through intermediate precursors that have not been unambiguously 
identified, but may include the early and common lymphoid progenitors (ELP and 
CLP), both of which are distinct from the fetal liver T/NK progenitor 3. Since B cell 
development in Cbfbrss/- mice is only mildly affected, the ELP and CLP are 
presumably present, and are apparently able to give rise to NKP.  
Other transcription factors are necessary for both T and NK cell 
development including members of the Ikaros, ETS, Id, and TCF7/LEF-1 families 
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59-68
.  However, mutations in none of these genes selectively and profoundly 
affected both T and NK, but not B cell development in mice. The profound T and 
NK cell defects we observed in Cbfbrss/- mice most closely resemble those 
associated with the T- B+ NK- forms of severe combined immune deficiency 
syndrome in humans, which are caused by mutations that affect both the IL-7 and 
IL-15 signaling pathways 69. Molecules in both pathways are regulated by the 
CBFs. The CBFs regulate CD122 (Il2rb) expression in NK1.1+ cells, and Runx1 is 
required for full activation of the Il7ra gene in DN2, DN3, and DP (TCRβhi CD69+) 
thymocytes and in Foxp3- CD4+ cells 11,48. We found essentially no CD122+ cells in 
ex vivo cultures of Cbfbrss/- Lin- cells or in the thymus. IL-7Rα levels were 
unchanged in Cbfbrss/- DN2 cells, but IL-7 signaling was nonetheless 
compromised, as levels of phosphorylated Stat5 were lower. However, defective 
JAK/STAT signaling is unlikely to be the only defect in Cbfbrss/- T and NK cells. 
Neither wildtype nor constitutively active Stat5a could rescue the T cell 
abnormalities, indicating that defective JAK/STAT signaling alone cannot explain 
the T cell defect. Egawa et al. 11 similarly concluded that defective IL-7 signaling 
was not the only factor limiting the number of Runx1-deficient CD4+ T cells. 
Furthermore, the defects in Cbfbrss/- cells are manifested before the IL-7 
dependent stage of T cell growth, as their inability to express Cd3e, Gata3, or 
Tcf7 is consistent with a profound regulatory defect in T cell specification. In NK 
cells CBFs appear to regulate multiple genes including the Ly49 family in mouse 
and the killer cell Ig-like receptors in human 70,71.  In the future, it will be 
interesting to explore whether abnormalities in Runx/CBFβ function might 
 only.
For personal use at CALIFORNIA INST TECH/MILLIKAN LIBRARY on April 5, 2008. www.bloodjournal.orgFrom 
                                 
 25
account for a subset of SCID patients with as of yet no identified mutations. 
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Figure legends 
 
Figure 1. T cell differentiation is blocked in a CBFβ dosage-dependent manner. 
A. Proliferation of Lin- (Ter119, CD19, Gr-1, F4/80) 17.5 dpc FL cells co-
cultured on OP9-DL1 in the presence of Flt3L and IL-7, counted at weekly 
intervals. Each data point is averaged from at least nine fetal livers. Error bars in 
all figures represent standard error of the mean (SEM).  
B. Bar graph depicting the fold expansion of Lin- FL cells from an allelic Cbfb 
dosage reduction series, following 14 days of OP9-DL1 co-culture. Error bars 
represent SEM. The percentage of CBFβ protein relative to wild type levels is 
indicated below the bars 13. The number of independent animals analyzed was: 
Cbfb+/+ = 13; Cbfb+/- = 7; Cbfbrss/rss = 5; Cbfbrss/- = 10. Single asterisks (*) indicate 
significant (P < 0.05) differences relative to Cbfb+/+ animals (unpaired, two-tailed 
Student’s t-test).  
C.  CD4 and CD8 expression following 14 days of co-culture on OP9-DL1.  
D. Mean (± SEM) percentages of CD4+ CD8+ (DP) cells. Cbfb+/+ = 17; Cbfb+/- = 7; 
Cbfbrss/rss = 5; Cbfbrss/- = 16. Single asterisks (*) indicate significant (P < 0.05) 
differences relative to Cbfb+/+ animals, and double asterisks (**) relative to 
Cbfbrss/rss animals. 
E. Cell surface TCRγ expression in the bulk co-cultured cells. 
F. Mean (± SEM) percentages of TCRγ+ cells after 14 days of culture. Cbfb+/+ = 
17; Cbfb+/- = 7; Cbfbrss/rss = 5; Cbfbrss/- = 16.  
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G. Intracellular TCRβ staining in DN cells (DN = CD8- Gr-1- since CD4 
expression is inappropriately unregulated in Cbfbrss/- DN cells 13,72) following six 
and nine days of OP9-DL1 culture. Cbfb+/+ = 4; Cbfbrss/- = 3. 
 
Figure 2. T cell specification fails to occur in Cbfbrss/- cells. 
A.  Lin- FL cells co-cultured on OP9-DL1 in the presence of Flt3L and IL-7 for 
seven days. CD8- Gr1- GFP- cells (GFP gating was used to eliminate OP9-DL1) 
were analyzed for CD44 and CD25 expression.  
B. Percentages of DN1, DN2, and DN3 cells (from A) averaged from 12 
independent experiments. Error bars represent SEM. The difference between the 
percentages of Cbfb+/+ and Cbfbrss/- cells was significant (*) at P ≤ 0.01. 
C. CD45+ Lin- (Lin = CD8, CD3, TCRβ, TCRγ, CD11c, B220, Mac1, NK1.1, 
Ter119) 17.5 dpc fetal thymocytes analyzed for CD44 and CD25 expression.  
D. Data from 6 animals of each genotype (from C). The difference between the 
percentages of Cbfb+/+ and Cbfbrss/- cells was significant (*) at P ≤ 0.03. 
 E. Expression of cell surface Thy1.2 on 17.5 dpc DN1 (Lin-CD45+CD44+CD25-) 
thymocytes, and on DN1 cells (CD8- Gr-1-CD45+CD44+CD25-) from day 6 OP9-DL1 
cultures. The thymocyte data were averaged from 4 Cbfb+/+ and 4 Cbfbrss/- fetuses, 
and the culture data from 4 Cbfb+/+ and 3 Cbfbrss/- fetuses. Asterisks indicate 
significant differences between Cbfb+/+ and Cbfbrss/- samples (P = 0.01). 
F. Percentage of 17.5 dpc DN thymocytes (CD45+ Lin-, Lin=CD8, CD3, CD11c, 
B220, Mac-1, Ter119) expressing intracellular TCRβ (iTCRβ) and iTCRγ. Data are 
averaged from 3 Cbfb+/+ and 3 Cbfbrss/- fetuses.  
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G. Percentage of Thy1.2+ DN2 cells following 7 days of OP9-DL1 culture. 
H. Cd3e and Cd3g expression by qRT-PCR in DN2 cells sorted from day 7 
OP9-DL1 cultures (culture conditions and staining as described in A). The purity 
of post-sort populations was > 95%. Expression of individual genes was 
normalized to Hprt. Data were derived from triplicate amplifications from three 
independent samples. Asterisks indicate significant differences between Cbfb+/+ 
versus Cbfbrss/- values (P ≤ 0.01).  
I. Lin- FL cells cultured on OP9-DL1 cells, harvested at indicated time points. 
DN1 cells (Lin- CD45+ CD44+ CD25-) were isolated by cell sorting (purity > 95%). 
The expression of individual genes was normalized to Hprt (note log scale for 
Tcf7) and displayed as relative to day 0 values of Cbfb+/+ DN1 cells. Values are 
averaged from triplicate samples isolated from three independent experiments. 
Asterisks indicate significant differences between Cbfb+/+ versus Cbfbrss/- values 
(P ≤ 0.05). 
J. Rescue of T cell development with CBFβ  in 17.5 dpc Cbfbrss/- FL cells. Lin- 
FL cells (E17.5) were transduced with the indicated retroviruses and co-cultured 
on OP9-DL1. Cells were harvested after two weeks and GFP+ CD45+ cells analyzed 
for CD4 and CD8 expression (top panels) and TCRγ expression (middle panels). 
The bottom two plots are DN cells analyzed after one week of co-culture. Gated 
GFP+ Lin- CD45+ cells were analyzed for expression of CD44 and CD25 
(nexperiments=11).  
K.  Western blot showing CBFβ(p22) protein levels resulting from retroviral 
expression relative to endogenous protein levels, in whole cell extracts prepared 
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from GFP+ CD45+ cells purified from the OP9-DL1 cultures of Lin- FL cells (CD45+ 
cell purity ≥ 99.9%). The blot was probed with a monoclonal antibody to CBFβ. 
The two endogenous CBFβ isoforms generated as a result of alternative splicing 
(p21.5 and p22) are both visible on this gel. Samples were normalized for actin 
expression, and the relative amounts of CBFβ determined from a dilution series 
(not shown). CBFβ levels in retrovirally-transduced cells were 5-fold higher than 
endogenous levels. Lanes: 1, Cbfbrss/- + MigR1; 2, Cbfbrss/- + CBFβ; 3, Cbfb+/+ + 
MigR1; 4, Cbfb+/+ + CBFβ 
L. Inefficient rescue of T cell development upon restoring CBFβ expression in 
17.5 dpc Cbfbrss/- thymocytes. Thymocytes were transduced with the indicated 
retroviruses and co-cultured for 7 days on OP9-DL1. Gated GFP+CD45+ cells were 
analyzed for CD4 and CD8 expression in the plots below.  GFP+CD45- cells are 
predominantly OP9-DL1 cells 16. 
M. Cell cycle status of CD45+ Lin- (Lin=CD8, TCRβ, TCRγ, CD11b, Ter119, B220) 
17.5 dpc fetal thymocytes.  
N. Summary of cell cycle data from 5 individual samples per genotype. The 
differences between Cbfb+/+ and Cbfbrss/- cells in G0/G1 and G2/M were significant 
at P ≤  0.01.  
 
 
Figure 3. JAK/STAT and c-kit signaling in Cbfbrss/- T cells. 
A. Expression of IL-7Rα (CD127) and γc (IL2RG/CD132) on the DN2 thymocytes 
from Figure 2C (17.5 dpc). Data are representative of four experiments.  
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B.  DN2 cells were sorted from OP9-DL1 cultures (culture conditions and 
staining as described in Figure 2A). The purity of post-sort populations was > 
95%. Expression of individual genes was normalized to Hprt. Values are averaged 
from triplicate samples from three independent experiments. Asterisks indicate 
significant differences (P ≤ 0.05). 
C. pStat5 levels in 17.5 dpc DN2 thymocytes upon ex vivo stimulation with 0, 1 
and 5 ng/ml IL-7 for 20 minutes. Shown is the MFI of the difference between 
pStat5 under IL-7 stimulated and non-stimulated conditions. The data are 
averaged from 5 Cbfb+/+ and 5 Cbfbrss/- fetuses. Differences are significant at 
P<0.0001. 
D. Rescue of T cell development from Cbfbrss/- Lin- FL cells with CBFβ, but not 
wild type or constitutively active Stat5a (S711F; Stat5aF), or MigR1 alone (-) (n=5). 
Cells were harvested after two weeks. The expansion of Cbfbrss/- cells (left graph) 
is calculated by dividing the number of GFP+ cells on day 14 by that on day 7 of 
culture. Only CBFβ expression significantly (*, P ≤ 0.0001) increased cell numbers 
compared to MigR1-transduced Cbfbrss/- cells. The right hand graph shows the 
percentage of GFP+ cells expressing CD4 and CD8. 
E. Expression of cell surface c-kit on 17.5 dpc DN1 cells. Bar graph on left is 
the percentage of c-kit+ DN1 (Lin- as in Fig 2B; CD45+CD44+CD25-) thymocytes, 
and on right is the MFI of c-kit staining on c-kit+ DN1 thymocytes. The data are 
averaged from 4 Cbfb+/+ and 4 Cbfbrss/- fetuses.  
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F. Percentage of DN1 (CD44+ CD25- CD45+ Lin-) cells expressing surface c-kit 
and MFI of c-kit staining on c-kit+ DN1 cells after six days of OP9-DL1 culture. The 
data are averaged from 4 Cbfb+/+ and 3 Cbfbrss/- fetuses. 
 
Figure 4. Notch signaling is active in Cbfbrss/- cells and NK cell development is 
defective. 
A.  Lin- FL cells cultured on OP9-DL1 cells, harvested at indicated time points 
and stained with antibodies as described in Figure 2A. DN1 cells (Lin- CD45+ 
CD44+ CD25-) were isolated by cell sorting (purity > 95%). The expression of 
individual genes was normalized to Hprt (note log scale for Dxt1) and displayed 
as relative to day 0 Cbfb+/+ DN1 cells. Values are averaged from 9 samples 
(triplicate samples from three independent experiments). Asterisks indicate 
significant differences between Cbfb+/+ versus Cbfbrss/- values (P ≤ 0.05). 
B.  Flow cytometric analysis of Lin- FL cells cultured on OP9-DL1 (+Flt3L, IL-7, 
IL-6, IL-15) in the absence and presence of the gamma secretase inhibitor (GSI) 
inhibitor X for 7 days. GFP- CD45+ cells were analyzed for expression of NK1.1 
(NK cells) and CD19 (B cells). nexperiments = 7.  
C. Lin- Cbfb+/+ 14.5 dpc FL cells transduced with either MigR1 or a retrovirus 
expressing the Notch1 intracellular domain (ICN) and cultured for 7 days on OP9 
stromal cells in the presence of Flt3L and IL-7. CD8- CD19- Gr1- cells were gated 
for GFP expression in the left hand panels, and GFP+ cells analyzed for CD44 and 
CD25 expression in the right hand panels. 
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D. Lin- Cbfbrss/- FL cells transduced with MigR1 or ICN, and analyzed as in 
panel C. 
 
Figure 5.  Inhibition of Notch signaling does not affect Runx1, Runx3, or Cbfb 
expression. 
A. Flow cytometric analysis of Lin- FL cells cultured on OP9-DL1 in the 
absence and presence of the indicated concentrations of GSI for 7 days. CD8- 
CD19- Gr1- GFP- cells were analyzed for CD44 and CD25 expression (nexperiments = 
8). 
B. Gene expression profile of DN1 cells sorted from day 7 OP9-DL1 co-
cultures treated with DMSO (white bars), 1.0 µM GSI (gray bars), or 3.0 µM GSI 
(black bars). Cell sorting, RNA preparation, and real-time PCR were performed as 
described in Figure 4A. Taqman probes were used for the quantification of 
Runx1, Runx3, Cbfb and Hprt, and SYBR green was used for the remainder of the 
genes. Expression of each gene was quantified in comparison to a standard 
curve prepared with dilutions of spleen cDNA. The expression of individual genes 
is displayed relative to Hprt. Data are averaged from four independent 
experiments. Error bars represent SEM and asterisks indicate significant 
differences between GSI treated and untreated cells (P ≤ 0.05).  
C. Runx1 expression in lymphoid progenitors (c-kit+CD27+CD25-) isolated 
from day 3 OP9-DL1 cultures in the absence and presence of 3 µM GSI (averaged 
from triplicate samples from three independent experiments). The increase in 
Runx1 expression in GSI-treated cultures was significant at P < 0.01. 
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D. Ectopic expression of Runx1 in Cbfb+/+ FL cells cultured on OP9-DL1 in the 
absence and presence of GSI at 3 µM. Analysis was performed as in panel A. 
 
Figure 6. CBFβ is required at an early stage of NK cell development in vivo. 
A. Representative scatter plots of Lin- 15.5 dpc FL cells grown on OP9 cells in 
the presence of Flt3L, IL-7, and IL-15. Gr-1-CD19- cells were analyzed for CD122 
and NK1.1 expression.  
B. Percentage and absolute number of CD122+ cells (±SD) harvested from OP9 
cultures established from 3 Cbfb+/+ and 4 Cbfbrss/- fetuses (nexperiments = 3). 
C. NK cells in 15.5 dpc fetal thymuses.  
D. Total number of thymic NK1.1+ and NK1.1+ CD122+ cells averaged from 3 
Cbfb+/+ and 3 Cbfbrss/- fetuses (nexperiments = 3). 
 
E-G.  Lethally irradiated CD45.1 x CD45.2 F1 recipients were reconstituted with 
wild-type CD45.1+ bone marrow and CD45.2+ FL cells from Cbfb+/+, Cbfbrss/rss or 
Cbfbrss/- fetuses (expressing 100%, 30% and 15% of normal CBFβ levels, 
respectively).  
E.  Bone marrow of recipient mice analyzed 10 months after reconstitution. 
The data are from gated FL-derived (CD45.2+) progenitors. A representative 
example is shown in each group (Cbfb+/+, n=4; Cbfbrss/rss, n=4; Cbfbrss/-, n=5). Bone 
marrow from a 10 week old C57BL/6 (B6) mouse is shown as control. CD19-CD3-
TCRβ-NK1.1+DX5+ cells are mature NK cells, while immature NK lineage cells (iNK) 
have a NK1.1+Dx5- phenotype.  
 only.
For personal use at CALIFORNIA INST TECH/MILLIKAN LIBRARY on April 5, 2008. www.bloodjournal.orgFrom 
                                 
 43
F.  The spleen of recipient mice analyzed in a similar way, illustrating the 
absence of immature and mature NK cells among cells derived from Cbfbrss/- 
progenitors.  
G.  Primitive NK lineage committed progenitors (NKP) (CD122/IL2Rβ+ NKG2D+ 
NK1.1- Dx5- LinT-) (LinT = CD3 CD4 CD8α TCRβ TCRγ) are preserved in the spleen 
of recipient mice. NKP express the IL-2/IL-15Rβ chain and have an NK1.1-Dx5- 
CD19-CD3-CD4-CD8a-TCRβ-TCRγ- phenotype. A fraction of these cells expresses 
NKG2D 3.  
H. Expression Runx1, Runx3, and Cbfb by qRT-PCR in LSK (Lin=CD4, CD8, 
TCRβ, TCRγ, DX5, CD19, Mac-1, Ter119), iNK (CD4- CD8- TCRβ- TCRγ- CD19- 
CD49b- NK1.1+ CD122+) and mature NK (CD4- CD8- TCRβ- TCRγ- CD19- CD49b+ 
NK1.1+ CD122+) cells sorted from bone marrow of 8 – 12 week old wild type mice. 
The purity of post-sort populations was > 98%. Expression of individual genes 
was normalized to Hprt. Asterisks indicate significant differences from LSK cell 
values (P ≤ 0.01). 
 
 
 
Figure 7. Genetic interactions between the CBFs and Notch signaling in the 
specification of HSCs, T, and NK cells in the fetus.  
Notch receptors and ligands are expressed on the aortic endothelial cells 
in the AGM region that give rise to HSCs 20. Notch signaling is required for Runx1 
expression in endothelial cells and for the formation of HSCs 19,20,23,24, and thus 
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Notch is genetically upstream of Runx1 in HSC formation. (Solid lines indicate 
molecular interactions, and dashed lines represent cell migrations. PB, peripheral 
blood.) 
HSCs and progenitors are released into the circulation from their sites of 
formation and colonize the fetal liver. We speculate that Runx1 and/or Runx3 plus 
CBFβ are required to generate NKP from either a bipotent T/NK or another 
progenitor in the fetus, and perhaps in T/NK progenitors themselves. CBFs are 
also required for the NKP to iNK transition, based on data from the adult.  
Circulating progenitors expressing all three CBF complexes colonize the 
thymus where they encounter high levels of Notch ligands. CBFs confer upon 
these progenitors the ability to respond to Notch signaling, which results in T cell 
specification and progression to the ETP/DN2 stage accompanied by the 
expression of a suite of T cell specific genes. Not shown are NKT cells, which 
differentiate from DP T cells in a Runx1-dependent manner.  
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Abstract 
 
CBFβ is the non-DNA binding subunit of the core binding factors (CBFs). Mice 
with reduced CBFβ levels display profound, early defects in T but not B cell 
development. Here we show that CBFβ is also required at very early stages of natural 
killer (NK) cell development. We also demonstrate that T cell development aborts during 
specification, as the expression of Gata3 and Tcf7, which encode key regulators of T 
lineage specification, is substantially reduced, as are functional thymic progenitors. 
Constitutively active Notch or IL-7 signaling cannot restore T cell expansion or 
differentiation of CBFβ insufficient cells, nor can overexpression of Runx1 or CBFβ 
overcome a lack of Notch signaling. Therefore the ability of the prethymic cell to 
respond appropriately to Notch is dependent on CBFβ, and both signals converge to 
activate the T cell developmental program.  
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Introduction 
 
T cell development begins with colonization of the thymus by rare circulating 
bone marrow-derived progenitors 1, which expand to generate a population of early T 
lineage progenitors (ETPs). ETPs then give rise in an orderly fashion to cells expressing 
both CD4 and CD8 (DP) via several intermediate CD4/CD8 double negative (DN) 
stages (DN2, DN3 and DN4) 2. The earliest intrathymic stages of T lineage 
development, proliferation, and survival require signaling through Notch, c-kit, and the 
IL-7 receptor, plus the activity of several transcription factors including core binding 
factors (CBFs), Gata3, E2A, c-myb, Ikaros, TCF/LEF, and Ets family members 2. Notch 
and the CBFs were shown to interact genetically in other contexts, although their 
genetic hierarchy during T cell development is unknown.  
Natural killer (NK) cells develop in multiple sites including liver (fetal and adult), 
bone marrow, spleen, and thymus 3,4. The first NK lineage committed progenitors can 
be identified through their expression of the IL-2/IL15Rβ chain (CD122) and the 
absence of lineage-specific and mature NK cell markers 3. The differentiation of NKP 
into immature and mature NK cells is exquisitely dependent on IL-15 signaling 3. NK cell 
development does not require signaling through the c-kit receptor 3, and sustained 
Notch signaling inhibits NK cell differentiation 5-7. Transcription factors required for NK 
cell development include Ets-1, MEF, Id2, TCF/LEF, and members of the Ikaros family 
3.  
CBFs are heterodimeric transcription factors consisting of a DNA binding subunit 
(Runx1, Runx2, or Runx3) and a non-DNA binding CBFβ subunit that increases the 
 3
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affinity of the Runx subunits for DNA. Homozygous disruption of Runx1 results in a 
failure of hematopoietic stem cell (HSC) emergence in the conceptus 8, and in the adult 
Runx1 is required for megakaryocyte, B, and T cell development 9,10. Conditional 
deletion of Runx1 in bone marrow progenitors using Mx1-Cre blocked T cell 
development at the DN2 to DN3 transition 9,10, while deletion in DN3 cells with Lck-Cre 
modestly impaired the formation of DN4 and intermediate single positive cells 11. Runx1 
deletion in DP cells with Cd4-Cre reduced the number of mature CD4+ cells and 
eliminated a specialized subset of T cells with NK markers 11,12. However, an earlier, 
collective role for CBFs in T cell development was revealed by a hypomorphic Cbfb 
allele (Cbfbrss) that, when carried over a nonfunctional Cbfb allele caused an 85% 
reduction in CBFβ protein levels 13. Although HSCs emerged in Cbfbrss/- fetuses and B 
cells were generated, there was a profound defect in T cell development with what 
appeared to be consecutive partially penetrant blocks in the generation of ETPs, DN2, 
and DN3 cells, and an almost complete absence of DN4 and DP cells 13. 
Notch proteins (Notch 1-4) are transmembrane receptors, that upon binding the 
cell surface ligands Delta-like or Jagged, undergo two proteolytic cleavages to release 
the Notch intracellular domain (ICN) 14. ICN translocates into the nucleus, where it binds 
to the CSL/RBP-J (CBF1/RBP-J, Suppressor of Hairless, Lag-1) transcription factor, 
displacing corepressors and recruiting coactivators of the Mastermind-like (MAML) 
family. Disruption of Notch signaling either by conditional deletion of Notch1, by 
conditional deletion of CSL, or through expression of a truncated, dominant negative 
form of MAML1 completely blocks T cell development, and results in the generation of 
intrathymic B cells 14. Conversely, Notch is sufficient to drive T cell development, since 
 4
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overexpression of a constitutively active form of Notch (ICN) leads to T cell at the 
expense of B cell development at extrathymic sites 14. Exposure of hematopoietic 
progenitors to plate- or cell-bound Notch ligands of the Delta-like family can drive T 
lineage development in culture 14-16. 
In two well-characterized examples in hematopoiesis Notch signaling was shown 
to function genetically upstream of the CBFs. Inactivation of Notch or its ligand Serrate 
in Drosophila caused the loss of Lozenge (a Runx homologue) expression in hemocyte 
progenitors 17, and mutations in Notch, Serrate, or Lozenge itself resulted in a failure to 
generate the subset of hemocytes called crystal cells 17,18. In mice, both Notch1 
signaling and Runx1 are required for hematopoietic cell emergence from the 
aorta/gonad/mesonephros (AGM) region 8,19-22. Notch1 signaling defects in mice and 
zebrafish impair Runx1 expression in the AGM region 19,20,23, and overexpression of 
Runx1 in Notch signaling mutants can rescue the emergence of hematopoietic cells 
from the AGM region, demonstrating that Runx1 is, at least in part, genetically 
downstream of Notch signaling 23,24.  
Here we characterized the molecular mechanism underlying the T cell defect 
caused by insufficient CBFβ levels. We show that T cell specification does not occur, as 
its multiple early markers (Gata3, Tcf7, Cd3e) fail to be expressed. Notch signaling is 
not impaired, and although IL-7 signaling is decreased, it is not solely responsible for 
the T cell defect. Finally, we show that reduced CBF levels cause an early and profound 
block in NK cell development, which is the first demonstration that the CBFs play an 
essential role in the NK cell lineage. 
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Materials and Methods 
Mice 
Generation and genotyping of the Cbfbrss (Cbfbtm2.1Spe) and Cbfb- (Cbfbtm1Spe) 
alleles were described previously 13,25.  The animal protocols used in these studies were 
approved by our Institutional Animal Care and Use Committees. 
 
Transplant analyses 
C57BL/6 (B6.SJL-Ptprc<a>Pep3<b>/BoyJ) x 129S1/SVImJ F1 mice 
(Ly5.1+/Ly5.2+) were subjected to two split doses of 550 Rads 3-4 hours apart. Each 
recipient received donor fetal liver (FL) and competitor bone marrow (BM) cells (2 X 10 5 
cells of each) via tail vein injection. All donor fetuses were of a mixed C57BL/6J and 
129S1/SVImJ background and expressed the Ly5.2 (CD45.2) haplotype. Whole BM 
competitor cells were prepared from C57BL/6 (B6.SJL-Ptprc<a>Pep3<b>/BoyJ) 
(Ly5.1+) mice.  
 
Flow cytometry and cell sorting 
Flow cytometric analyses were performed on a dual-laser FACSCalibur, 
FACSCanto, or on a four-laser LSRII (BD Biosciences). The following antibodies were 
purchased from PharMingen (San Diego, CA), Ebiosciences (San Diego, CA) or 
Biolegend (San Diego, CA): CD3ε (145-2C11), CD4 (RM4-5), CD8α (53-6.7), CD11b 
(M1/70), CD11c (HL3), CD19 (1D3), CD25 (7D4), CD27 (LG.7F9), CD44 (IM7), CD45 
(30-F11), B220 (RA3-6B2), Gr-1 (RB6-8C5), CD127/IL-7Rα (A7R34), TCRβ (H57-597), 
TCRγ (GL3), NK1.1 (PK136), CD49b (DX5), CD122 (TM-b1), CD132 (4G3), NKG2D 
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(CX5), CD45.1 (A20), CD45.2 (104), Thy1.2 (53.2.1), c-kit (2B8), and pStat5 (47). On 
the LSRII platform, doublets were excluded through their FSC-W and SSC-W 
characteristics and DAPI was used for dead cell exclusion. The data were analyzed 
using FlowJo (version 6.1.1, Tree Star, San Carlos, CA). Cells were sorted on a 
FACSAria (BD Biosciences).  
 
Cell cycle analysis 
Fetal thymocytes (17.5 dpc) were stained with FITC conjugated antibodies (CD8, 
TCRβ, TCRγ, CD11b, Ter119, B220) and subsequently cultured in DMEM with 10% 
FBS and pulsed with BrdU (BD Bioscience) for one hour. Cells were harvested and 
stained with anti-BrdU APC, CD45 PerCP-Cy5.5 and 7-AAD. 
 
In vitro IL-7 stimulation and intracellular staining for TCRβ, TCRγ, and pStat5 
Fetal thymocytes (17.5 dpc) were stained with FITC conjugated lineage 
antibodies (CD8, CD3, TCRβ, TCRγ, CD11c, B220, NK1.1, Mac1, Ter119) as described 
elsewhere 26,27. Thymocytes were then incubated at 37°C for 20 min in DMEM 
(Invitrogen, Carlsbad, CA) with 10% FBS, then treated with 0, 1, and 5 ng/ml IL-7 for an 
additional 20 min. At the end of the stimulation, cells were immediately fixed with 1.6% 
formaldehyde at room temperature for 10 minutes, and permeabilized in ice-old 
methanol for 20 minutes. Cells were stained with PE-conjugated anti-phospho-STAT-5 
(Tyr694) plus antibodies to CD44, CD25, and CD45. The analysis of intracellular TCR 
staining was performed using the same protocol minus the incubation and cytokine 
stimulation. 
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Enrichment of FL progenitors and OP9 co-cultures 
Lineage negative (Lin-) FL cells (E14.5–E17.5) were isolated by depletion of Lin+ 
(CD19, Gr1, Ter119, F4/80) cells using MACS LS columns (Miltenyi Biotech, Auburn, 
CA). An anti-IL-7Rα biotin labeled antibody was included in the lineage cocktail in 
experiments in which Notch signaling was inhibited by GSI.  
OP9 and OP9-DL1 cells 16 were cultured in Minimum Essential Medium Alpha 
supplemented with 20% FBS (Invitrogen). Co-cultures were performed in 24-well plates 
by adding 1-5 × 105 Lin- cells to confluent OP9-DL1 monolayers along with 5 ng/mL 
human Flt3L and 1 ng/mL murine IL-7 (PeproTech, Rocky Hill, NJ). IL-6 (1 ng/ml) and 
25 ng/ml IL-15 were included in the cultures to enhance the generation of T, B and NK 
cells. Various concentrations of γ-Secretase Inhibitor X (GSI) (InSolutionTM, EMD 
Biosciences, San Diego, CA) in DMSO were added to the cultured cells. Co-cultured 
cells were harvested and analyzed weekly unless otherwise indicated.  
 
Retroviral infection of hematopoietic progenitors 
cDNAs encoding Runx1 (AML1b), the CBFβ heterodimerization domain (aa 1-
141), full length CBFβ, Stat5a, and Stat5aF were subcloned into the bicistronic MigR1 
retrovirus 28. MigR1 expressing the Notch ICN was previously described 29. Retroviruses 
were produced in Phoenix cells. One milliliter of viral supernatant, polybrene (2 ng/ml) 
and cytokines (IL-7 and Flt3L) were added to overnight co-cultures of Lin- FL cells or 
thymocytes on OP9-DL1 in 24-well plates and spinoculated at 1400 g at room 
 8
 only.
For personal use at CALIFORNIA INST TECH/MILLIKAN LIBRARY on April 5, 2008. www.bloodjournal.orgFrom 
                                 
temperature for 2 hours. The media was changed 24 hours post spinoculation and the 
co-culture continued as described above. 
 
Quantitative RT-PCR 
Total RNA was extracted from sorted or unsorted cells using the RNeasy Mini Kit 
and DNase I treatment (Qiagen, Valencia CA). RNA quality was assessed on agarose 
gels and quantified by Nano-Drop1000 (Nano-Drop, Wilmington, DE). First strand cDNA 
was generated using reverse transcriptase SuperscriptIII (Invitrogen) and oligo (dT)20 
primers. Real-time PCR was performed in triplicate on Applied Biosystems' 7500 Real-
Time PCR System (Foster City, CA). Either Taqman probes or SYBR-Green (Applied 
Biosystems) were used to detect gene expression. The following pre-made mixture of 
primers and Taqman probes were used: Runx1 (Mm00486762_m1); Runx3 
(Mm00490666_m1); Cbfb (Mm00491551_m1); Jak1 (Mm00600614_m1); Jak3 
(Mm00439962_m1); Stat3 (Mm00456961_m1); Stat5a (Mm00839861_m1); Stat5b 
(Mm00839861_m1); Hprt1 (Mm00446968_m1).  
The following primers were used for SYBR Green detection: Dtx1   
For TGAGGATGTGGTTCGGAGGT, Rev CCCTCATAGCCAGATGCTGTG; Hprt 
For CTCCTCAGACCGCTTTTTGC, Rev TAACCTGGTTCATCATCGCTAATC; Notch1 
For CAGCTTGCACAACCAGACAGAC, Rev ACGGAGTACGGCCCATGTT. Primers for 
Pu.1, Cd3g and Cd3e were described previously 30,31. Absolute quantification of each 
gene was calculated by the standard curve method using 10-fold dilutions of a positive 
control (spleen cell cDNA). Expression of individual genes was normalized to Hprt 
expression. 
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Western blot analysis 
GFP+ cells were sorted from OP9-DL1 co-cultures (purity >99.9%) and resuspended at 
1x 105 cells per ml in lysis buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 1% Nonidet P-40, 
0.5% deoxycholate, 0.1% SDS, 0.2 mM EDTA, 2.0 mM EGTA plus 1 μg/ml pepstatin A, 
1 μM Pefablock, 2 μg/ml leupeptin, 2 μg/ml aprotinin). Lysates were boiled in SDS 
loading buffer, resolved by SDS-PAGE through 4 - 12% Bis-Tris gels (Invitrogen), 
proteins transferred to nitrocellulose and the blot probed with a mouse monoclonal 
antibody to CBFβ (β141.2) 25. The blots were developed with ECL reagents (Pico kit, 
Pierce, Rockford, IL).  
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Results 
 
The T cell defect exhibited by Cbfbrss/- cells is recapitulated ex vivo. 
We previously assessed the collective role of core binding factors in 
hematopoiesis by using a hypomorphic allele of the common non-DNA binding CBFβ 
subunit gene (Cbfbrss). Cbfbrss/- fetal liver (FL) cells (expressing approximately 15% of 
normal CBFβ levels) contained HSCs that could contribute to the formation of myelo-
erythroid and B lineage cells, but not to DN4 or DP T cells13. To further investigate the 
molecular basis of this defect, we cultured Lin- FL progenitors from 14.5 – 17.5 days 
post coitus (dpc) mice on OP9 stromal cells expressing the Notch ligand Delta-like1 
(OP9-DL1 cells) to induce T cell differentiation ex vivo 16. Within two weeks after 
establishing the OP9-DL1 co-cultures, Cbfb+/+ progenitors underwent extensive 
proliferation (Fig 1A,B), and approximately half became CD4/CD8 double positive (DP) 
(Fig 1C,D) and gave rise to clear populations of TCRβ+ (not shown) and TCRγ+ cells 
(Fig 1E,F). In contrast, the in vitro expansion of Cbfbrss/- cells was significantly 
depressed (Fig 1A,B). Cbfbrss/- progenitors generated very few DP cells (Fig 1C,D), 
TCRγ+ cells (Fig 1E,F), or TCRβ+ cells (not shown), and the DN cells contained no 
detectable intracellular TCRβ (Fig 1G).  Cbfbrss/rss Lin- FL cells, which have higher CBFβ 
levels than Cbfbrss/- cells 13, also produced fewer cells and a significantly smaller 
percentage of TCRγ+ cells (Fig 1B,F), however the defects were not as pronounced as 
those of Cbfbrss/- cells, indicating that T cell development was affected in a dose 
dependent manner ex vivo.  
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Cbfbrss/- cells fail to undergo T lineage specification 
We examined the DN populations to more precisely define the T cell 
developmental defect caused by reduced CBFβ dosage. Following seven days of 
culture on OP9-DL1, most Cbfb+/+ Lin- FL cells had progressed to the DN2 and DN3 
stages, whilst the majority of Cbfbrss/- cells were arrested prior to the DN2 stage (Fig 
2A,B). Thymocytes from 16.5-17.5 dpc Cbfbrss/- fetuses also exhibited an early T cell 
developmental arrest, but a higher percentage of thymocytes appeared to progress to 
the DN2 and DN3 stages (Fig 2C,D). We suspect that the lower numbers of phenotypic 
DN2 and DN3 cells generated ex vivo may be caused by differences in the quality or 
intensity of signaling provided by OP9-DL1 cells as compared to thymic stromal cells.  
We examined Cbfbrss/- DN cells for molecular markers of T cell differentiation. 
Thy1.2+ DN1 thymocytes were present in Cbfbrss/- 17.5 dpc fetuses, but in significantly 
reduced numbers (Fig 2E). Cbfbrss/- DN thymocytes contained no intracellular TCRβ or 
TCRγ chains, which are normally found in DN3 and DN4 cells, respectively 32, indicating 
that development arrested before the commitment stage  (Fig 2F). The ex vivo defect 
was more pronounced, as Thy1.2+ cells were absent in the DN1 population (Fig 2E), 
although most thymocytes that progressed to the DN2 stage did express Thy1.2 (Fig 
2G). Cd3e expression, which can normally be found in both DN1 and DN2 cells 33 was 
essentially undetectable in Cbfbrss/- DN2 cells purified from the OP9-DL1 cultures, and 
Cd3g mRNA levels were significantly reduced (Fig 2H). Gata3 and Tcf7 expression 
progressively increased in wild type DN1 (Fig 2I) and DN2 (not shown) cells over a five-
day culture period 30, but remained low and unchanged in Cbfbrss/- DN1 and DN2 cells. 
PU.1 expression was not elevated in the Cbfbrss/- DN1 population, suggesting re-
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specification into myeloid lineage cells had not occurred 30.  
To determine whether Cbfbrss/- fetuses contained functional thymic progenitors, 
we attempted to rescue T cell development by reintroducing CBFβ into Cbfbrss/- 
thymocytes. Although we could successfully rescue the formation of DP, TCRγ+, and 
DN2-DN4 cells following retroviral transduction of CBFβ into Lin- Cbfbrss/- FL progenitors 
(Fig 2J,K), we could not efficiently rescue T cell development from Cbfbrss/- fetal 
thymocytes (Fig 2L). We could transduce wild type thymocytes with GFP-expressing 
retroviruses and recover GFP+CD45+ and GFP+DP cells, thus our retroviral 
transductions were effective. However, we could recover only very few GFP+CD45+ 
cells from Cbfbrss/- thymocytes transduced with a bicistronic virus expressing both 
CBFβ  and GFP, although these included DP cells (Fig 2L). Cbfbrss/- DN thymocytes 
were actively cycling (Fig 2M,N), thus it is unlikely that our failure to rescue T cell 
development is due to a lack of cells permissive for retroviral transduction. We conclude 
that Cbfbrss/- thymi contain very few functional T cell progenitors. Altogether, these data 
indicate that Cbfbrss/- cells have a global, early defect in T cell specification.  
 
IL-7 signaling and c-kit expression in Cbfbrss/- cells 
We determined if CBFβ insufficiency affected the expression or activity of one or 
more signaling pathways required at early stages of T cell development. IL-7 signaling 
is essential at the DN1 and DN2 stages, and cell surface IL-7Rα levels become 
elevated at the DN2 stage 34-38. CBFs directly activate the Il7ra (IL-7Rα) gene at later 
stages of T cell differentiation, in DP and CD4+ cells 11,39. We found that the mean 
fluorescence intensity (MFI) of IL-7Rα (CD127) staining was comparable in Cbfb+/+ and 
 13
 only.
For personal use at CALIFORNIA INST TECH/MILLIKAN LIBRARY on April 5, 2008. www.bloodjournal.orgFrom 
                                 
Cbfbrss/- DN2 thymocytes, and that of the common gamma chain (γc/IL2RG/CD132) was 
approximately 2.5 fold higher (Fig 3A). However, the levels of mRNAs encoding several 
IL-7 signaling molecules, including Jak1, Stat5a, and Stat5b, were significantly (~2 fold) 
lower in Cbfbrss/- DN2 cells (Fig 3B) and intracellular pStat5 levels were decreased by 
~7 fold (Fig 3C). Decreased JAK/STAT signaling, though, cannot be solely responsible 
for the T cell expansion or differentiation defects, as neither could be reversed upon 
expressing a wild type or constitutively active form of Stat5a 40 (Fig 3D).  
c-kit signaling is also critical for the proliferation and differentiation of DN1 and 
DN2 cells 38,41. We found that neither the percentage of c-kit+ DN1 thymocytes, nor the 
MFI of c-kit staining was altered in Cbfbrss/- fetuses (Fig 3E). The percentage of c-kit+ 
cells and staining intensity was also similar in Cbfb+/+ and Cbfbrss/- DN1 cells derived 
from OP9-DL1 cultures (Fig 3F). Therefore the T cell defect does not appear to be 
caused by reduced cell surface c-kit expression, although deficiencies in c-kit signaling 
were not examined and cannot be ruled out. 
 
Notch signaling is active in Cbfbrss/- cells 
To examine the ability of Cbfbrss/- progenitors to receive Notch signals, we 
purified the DN1 population from OP9-DL1 co-cultures at days 3, 4 and 5, and 
quantified the expression of Notch1 and several of its target genes by qRT-PCR (Fig 
4A). Notch1 was expressed in Cbfbrss/- cells at all time points examined, although its 
levels were reduced approximately 2 fold in freshly isolated “DN1”  (i.e. Lin- CD45+ 
CD44+CD25-) FL cells (day 0) and in DN1 cells isolated after three days of culture on 
OP9-DL1 cells, and slightly more than two fold at days 4 and 5 of culture. Expression of 
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the Notch1 target genes Hes1 and Hes5 were reduced ≤ 2-fold in Cbfbrss/- `DN1 cells at 
all time points examined (Fig 4A). Deltex1 (Dtx1) expression is known to be a very 
sensitive indicator of Notch signaling 42-44, and was reduced almost 10 fold in Cbfbrss/- 
DN1 cells by days 4 and 5 of culture. Although this is a substantial decrease, Dtx1 
levels did in fact increase in Cbfbrss/- DN1 cells approximately 100-fold during the culture 
period. Thus, although there were significant reductions in the expression of Notch1 and 
several of its target genes, the fact that their expression was not completely absent and 
was significantly induced after exposure to Notch ligands suggested that Notch 
signaling was active in Cbfbrss/- cells. Differences in the initial composition of the DN1 
population that could change further over the culture period could account for the 
relative decreases in the levels of Notch1 and its targets, due to enrichment of the 
Cbfb+/+ (but not the Cbfbrss/-) DN1 population for T lineage-specified cells. 
To determine if Notch signaling was functionally intact, we treated OP9-DL1 co-
cultures with a γ-secretase inhibitor (GSI) to block Notch signaling. When Notch 
signaling is blocked in wild type progenitors, B cells will develop at the expense of T 
cells 45,46. Since OP9-DL1 co-cultures of Cbfbrss/- Lin- cells did not contain CD19+ B cells 
(Fig 4B), nor were B cells detected in thymi of mice transplanted with Cbfbrss/- FL cells 
13, this suggested that Notch signaling was actively repressing B cell development. As 
expected, inhibition of Notch signaling with 1 μM and 3 μM GSI resulted in the 
differentiation of CD19+ B cells from Cbfb+/+ Lin- cells (Fig 4B). GSI even more efficiently 
induced the formation of B cells from Cbfbrss/- Lin- cells, confirming that Notch1 signaling 
was sufficiently active in Cbfbrss/- cells to repress B cell fate (Fig 4B). An increase in 
NK1.1+ NK cells was also observed in Cbfb+/+ co-cultures treated with GSI, but not in 
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Cbfbrss/- co-cultures. Thus Cbfbrss/- cells had a defect in NK cell development, which will 
be discussed in more detail later. 
Although Notch signaling in Cbfbrss/- cells was adequate to suppress B cell 
development, higher levels of Notch signaling are required to drive T cell development 7. 
Therefore to confirm that the lower levels of Notch1, or other defects in Notch signaling 
were not the underlying cause of the T cell developmental defect, we transduced 
Cbfbrss/- Lin- FL cells with a retrovirus expressing the constitutively active intracellular 
form of Notch1 (ICN). Cbfb+/+ cells expressing high levels of ICN (based on the 
surrogate GFP marker) efficiently differentiated into DN2 and DN3 cells following seven 
days of culture on OP9 cells (Fig 4C). On the other hand, Cbfbrss/- progenitors 
expressing ICN grew poorly, giving rise to a low percentage of GFP+ cells (1.7% ± 0.5% 
versus 66.6% ± 15.0% for Cbfb+/+ cells), and only a few of those cells differentiated to 
and past the DN2 stage (Fig 4D). Thus, constitutively high levels of Notch signaling did 
not rescue T cell development, but instead selected against the growth or survival of 
Cbfbrss/- cells. Since high levels of Notch signaling efficiently block B and NK cell 
development 47, and T cell development from Cbfbrss/- progenitors could not be rescued 
by ICN, the ICN-expressing Cbfbrss/- cells could not differentiate into the T, NK or B cell 
lineages, and appeared to be selected against, thus yielding relatively few GFP+ cells in 
the cultures. Therefore the moderate decrease in Notch1 expression, or potential 
defects in ligand binding or cleavage of the Notch receptor are unlikely to be 
responsible for the Cbfbrss/- early T cell defect but in fact may be selectively enriched to 
permit survival of the Cbfbrss/- cells. 
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Runx1, Runx3, and CBFβ expression are not dependent upon Notch signaling. 
Runx1 expression is activated by Notch signaling during hematopoietic stem cell 
development 19,20,23,24, thus we determined whether Runx1, Runx3, or Cbfb expression 
in T cells also required Notch signaling. Addition of 1 μM and 3 μM GSI to Cbfb+/+ OP9-
DL1 co-cultures impaired the differentiation of DN2 and DN3 cells in a dose dependent 
manner (Fig 5A). Expression of the Notch1 targets Hes1 and Dtx1 was significantly 
decreased in DN1 cells, as was Gata3 and Tcf7 (Fig 5B), demonstrating that Notch 
signaling and T cell development were indeed inhibited at the 3 μM GSI concentration. 
However, Runx1, Runx3, and Cbfb expression did not significantly change in DN1 cells 
in the presence of GSI, consistent with the conclusion that none of these genes are 
downstream activated targets of Notch1 in early T lineage progenitors (Fig 5B).  Since 
heterogeneity of the DN1 population could obscure modest changes in gene 
expression, we purified c-kit+CD27+CD25- lymphoid progenitors from the DN1 
population 30 and assessed Runx1 expression (Fig 5C). Inhibition of Notch signaling 
with 3 μM GSI resulted in a small but significant increase in Runx1 mRNA levels in c-
kit+CD27+CD25- cells, confirming that Runx1 expression in lymphoid progenitors does 
not require Notch signaling. Moreover, retroviral overexpression of neither Runx1 (Fig 
5D) nor CBFβ (not shown) in Cbfb+/+ progenitors treated with 3 μM GSI could rescue the 
perturbation in T cell development caused by inhibition of Notch signaling, supporting 
the hypothesis that blocking Notch signaling does not impair T cell development by 
affecting Runx1, Runx3, or Cbfb expression.  In summary, the activity of the Notch 
pathway does not depend on the CBFs, nor does CBF expression require Notch 
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activity. Rather, Notch and CBF expression and activity are independently regulated in 
uncommitted thymic progenitors, and converge to specify the T cell lineage. 
  
CBFβ is required for NK cell development 
 Although Cbfbrss/- Lin- cells were capable of producing B cells, we observed a 
defect in NK cell development when Notch signaling was inhibited (Fig 4B). We 
examined this more directly by culturing Lin- FL cells on OP9 stromal cells in the 
presence of Flt3L, IL-7, and IL-15. CD122 (IL2Rβ) is a subunit of the IL-15 receptor and 
is regulated by the CBFs 48. Cbfb+/+ Lin- FL cells generated a large number of CD122+ 
cells, including NK1.1+ CD122+ NK cells and NK1.1- CD122+ NK progenitors (NKP). 
Cbfbrss/- Lin- FL cells, on the other hand, produced very few CD122+ cells (Fig 6A,B) that 
would be capable of responding to IL-15 signaling. These data indicate that ex vivo NK 
cell development from fetal liver cells was blocked very early, prior to the NKP stage.  
To assess whether there was also an in vivo NK cell defect, we examined 
thymuses from 15.5 dpc Cbfbrss/- fetuses for NK cells. Bipotent T/NK progenitors and 
mature NK cells in the fetal thymus both express NK1.1 49. Cbfbrss/- fetal thymuses 
contained very few NK1.1+ (or NK1.1+ CD122+) cells (Fig 6C,D), indicating that almost 
no mature NK cells or bipotent T/NK progenitors were present. We also examined mice 
transplanted with Cbfb+/+, Cbfbrss/rss, and Cbfbrss/- 17.5 dpc FL cells 13 for the presence of 
donor-derived NK cells. As expected, there were no or very few donor-derived T cells in 
the bone marrow or spleen of mice transplanted with Cbfbrss/- FL cells (Fig 6E,F). Donor-
derived mature NK cells were present in the peripheral blood (not shown), bone marrow 
(Fig 6E), spleen (Fig 6F) and thymus (not shown) of transplant recipients of Cbfb+/+ and 
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Cbfbrss/rss FL cells. However Cbfbrss/- donor-derived mature and immature NK cells (NK 
and iNK) were completely absent in recipients reconstituted with Cbfbrss/- FL cells (Fig 
6E,F). We also observed a decreased contribution of Cbfbrss/- FL cells to CD19+ B cells 
in the bone marrow, but this decrease was not observed in the spleen, suggesting 
peripheral compensation for a partial defect in bone marrow B cell development (Fig 
6E,F). The precipitous decline in NK cell development that occurred when the CBFβ 
concentration dropped from 30% (Cbfbrss/rss) to 15% (Cbfbrss/-) of normal levels mirrored 
the abrupt and profound T cell defects we observed at this same transition 13, indicating 
that both early T and NK cell development require a similar threshold level of CBFβ. We 
also examined the transplant recipients for committed NKP (Fig 6G). The percentage of 
donor-derived NK cells and their precursors in both bone marrow and spleen of the 
transplant recipients was lower than in the C57BL/6 (B6) control, perhaps because of 
the more advanced age of the transplant recipients. This precluded evaluation of donor-
derived NKP in the bone marrow, however we were able to detect NKP in the spleen. 
Mice transplanted with Cbfb+/+, Cbfbrss/rss, and Cbfbrss/- FL cells all contained a 
detectable population of NKP in their spleen (Fig 6G). Therefore the NK cell deficiency 
in transplanted adult mice occurred at the NKP to iNK transition, whereas in the fetal 
liver and thymus it preceded the emergence of NKP.  
We (and others) examined the expression of core binding factor genes in iNK 
and NK cells purified from wild type mice to ascertain which members of the Runx 
family might be required in NK cells 48. Runx1, Runx3, and Cbfb mRNA were all found in 
Lin-Sca-1+c-kit+ bone marrow progenitors, iNK, and NK cells, and both Runx3 and Cbfb 
mRNA levels increased during NK cell differentiation (Fig 6H). Runx2 mRNA levels 
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were very low in Lin-Sca-1+c-kit+, iNK, and NK cells (not shown). Based on expression 
levels we predict that Runx1 and/or Runx3 are the Runx subunits most likely to be 
involved in NK cell development. 
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Discussion 
The CBFs and Notch cooperate in early T cell development 
We endeavored to define the molecular mechanisms underlying the requirement 
for CBFs in early T cell development by examining the expression of T cell specific 
genes, and signaling pathways important for T cell development in mice with reduced 
CBFβ levels. A small percentage of Cbfbrss/- cells reached the DP stage of T cell 
development when cultured on OP9-DL1 stromal cells, although the absolute number of 
cells that progressed past the DN1 stage was extremely low. The vast majority of 
Cbfbrss/- cells expressed very little if any Cd3e, Gata3, or Tcf7 mRNA, and no 
intracellular TCRγ or TCRβ chains were present. Thus, Cbfbrss/- cells lacked some of the 
earliest and most critical mediators of T-lineage development, indicating that T-lineage 
specification had essentially failed to occur. Although Cbfbrss/- cells were competent to 
receive Notch signals and by virtue of that were restrained in their ability to undergo B 
cell development, they could not integrate the Notch signal in order to fully activate the 
T lineage program. Thus CBFs are needed to establish a T-lineage inducible state that 
is competent to respond to Notch signaling.  
The mechanisms by which the CBFs and Notch signaling converge to specify T cells 
are unknown. One possibility is that they integrate at the level of common target genes 
in ETPs and at subsequent stages of DN thymocyte development. A few bona fide 
direct Notch targets are known in mammals, the best examples of which are the 
Hairy/Enhancer of SPLIT (HES) genes 50. Although no HES genes have been 
implicated as direct CBF targets, the mammalian HES-1 protein has been shown to 
physically interact with both Runx1 and Runx2, and HES-1 can potentiate Runx2 
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transactivation in reporter assays 51. Thus one mechanism by which Notch and CBFs 
may integrate their function is through the direct interaction of Runx and HES proteins. 
Genes such as Il2ra that encodes the CD25 molecule could be directly and coordinately 
regulated by Notch and the CBFs 39,43,52.  
Our observations during T cell development contrast with the initial stages of 
hematopoiesis in vertebrates, where Runx1 expression is dependent upon Notch1 
signaling (Fig 7), and overexpression of the mammalian or zebrafish Runx1 protein 
could rescue hematopoiesis from the AGM region in Notch mutant animals 19,20,23,24,53. 
In contrast, neither Runx1 nor CBFβ expression was decreased, nor could 
overexpression of Runx1 nor CBFβ restore T cell development when Notch signaling 
was inhibited. 
 
Defects in both early T and NK cell development implicate pathways essential for both 
lineages 
Although we could restore T cell development when we overexpressed CBFβ in 
Cbfbrss/- Lin- FL cells, we were unable to efficiently restore proliferation or T cell 
differentiation from Cbfbrss/- thymocytes. One possible explanation for this failure is that 
the defect may originate in a prethymic T cell progenitor, and as a result very few of 
them emigrate to the thymus, or they fail to proliferate or survive once they arrive. The 
majority of T cell progenitors in the fetal liver and thymus have both T and NK cell 
potential 54-58, and a defect within this population could also account for the lack of NK 
cells we observed in OP9 cultures of fetal liver cells, and in the fetal thymus. Both the T 
and NK cell defects became pronounced when CBFβ levels were reduced from 30% to 
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15% of normal levels, consistent with the hypothesis that they be ultimately traced, in 
part, to perturbations in the expression of genes required in both lineages, or to a 
common progenitor. Preliminary data indeed suggest that 12.5 dpc Cbfbrss/- fetal livers 
contained 6 to 7-fold fewer phenotypic (c-kit+ CD127+ PIR-A+) trilineage T, NK, and 
dendritic cell  (T/NK/DC) progenitors 55 (not shown). Furthermore, fetal thymuses 
contained only very low numbers of NK1.1+ cells, which include all the bipotent T/NK 
progenitors and mature NK cells 49. The small number of Cbfbrss/- T/NK progenitors that 
do colonize the thymus may, in addition, be functionally defective, perhaps because 
they have undergone irreversible epigenetic changes, or were unresponsive to the 
cytokines (Flt3L and IL-7) that we used in the transduction cocktail.  
 The NK cell defect in the transplanted adult mouse appeared to occur somewhat 
later, at the transition between NKP and iNK cells. NKP differentiate from the HSC 
through intermediate precursors that have not been unambiguously identified, but may 
include the early and common lymphoid progenitors (ELP and CLP), both of which are 
distinct from the fetal liver T/NK progenitor 3. Since B cell development in Cbfbrss/- mice 
is only mildly affected, the ELP and CLP are presumably present, and are apparently 
able to give rise to NKP.  
Other transcription factors are necessary for both T and NK cell development 
including members of the Ikaros, ETS, Id, and TCF7/LEF-1 families 59-68.  However, 
mutations in none of these genes selectively and profoundly affected both T and NK, 
but not B cell development in mice. The profound T and NK cell defects we observed in 
Cbfbrss/- mice most closely resemble those associated with the T- B+ NK- forms of severe 
combined immune deficiency syndrome in humans, which are caused by mutations that 
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affect both the IL-7 and IL-15 signaling pathways 69. Molecules in both pathways are 
regulated by the CBFs. The CBFs regulate CD122 (Il2rb) expression in NK1.1+ cells, 
and Runx1 is required for full activation of the Il7ra gene in DN2, DN3, and DP (TCRβhi 
CD69+) thymocytes and in Foxp3- CD4+ cells 11,48. We found essentially no CD122+ 
cells in ex vivo cultures of Cbfbrss/- Lin- cells or in the thymus. IL-7Rα levels were 
unchanged in Cbfbrss/- DN2 cells, but IL-7 signaling was nonetheless compromised, as 
levels of phosphorylated Stat5 were lower. However, defective JAK/STAT signaling is 
unlikely to be the only defect in Cbfbrss/- T and NK cells. Neither wildtype nor 
constitutively active Stat5a could rescue the T cell abnormalities, indicating that 
defective JAK/STAT signaling alone cannot explain the T cell defect. Egawa et al. 11 
similarly concluded that defective IL-7 signaling was not the only factor limiting the 
number of Runx1-deficient CD4+ T cells. Furthermore, the defects in Cbfbrss/- cells are 
manifested before the IL-7 dependent stage of T cell growth, as their inability to express 
Cd3e, Gata3, or Tcf7 is consistent with a profound regulatory defect in T cell 
specification. In NK cells CBFs appear to regulate multiple genes including the Ly49 
family in mouse and the killer cell Ig-like receptors in human 70,71.  In the future, it will be 
interesting to explore whether abnormalities in Runx/CBFβ function might account for a 
subset of SCID patients with as of yet no identified mutations. 
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Figure legends 
 
Figure 1. T cell differentiation is blocked in a CBFβ dosage-dependent manner. 
A. Proliferation of Lin- (Ter119, CD19, Gr-1, F4/80) 17.5 dpc FL cells co-cultured on 
OP9-DL1 in the presence of Flt3L and IL-7, counted at weekly intervals. Each data point 
is averaged from at least nine fetal livers. Error bars in all figures represent standard 
error of the mean (SEM).  
B. Bar graph depicting the fold expansion of Lin- FL cells from an allelic Cbfb 
dosage reduction series, following 14 days of OP9-DL1 co-culture. Error bars represent 
SEM. The percentage of CBFβ protein relative to wild type levels is indicated below the 
bars 13. The number of independent animals analyzed was: Cbfb+/+ = 13; Cbfb+/- = 7; 
Cbfbrss/rss = 5; Cbfbrss/- = 10. Single asterisks (*) indicate significant (P < 0.05) 
differences relative to Cbfb+/+ animals (unpaired, two-tailed Student’s t-test).  
C.  CD4 and CD8 expression following 14 days of co-culture on OP9-DL1.  
D. Mean (± SEM) percentages of CD4+ CD8+ (DP) cells. Cbfb+/+ = 17; Cbfb+/- = 7; 
Cbfbrss/rss = 5; Cbfbrss/- = 16. Single asterisks (*) indicate significant (P < 0.05) 
differences relative to Cbfb+/+ animals, and double asterisks (**) relative to Cbfbrss/rss 
animals. 
E. Cell surface TCRγ expression in the bulk co-cultured cells. 
F. Mean (± SEM) percentages of TCRγ+ cells after 14 days of culture. Cbfb+/+ = 17; 
Cbfb+/- = 7; Cbfbrss/rss = 5; Cbfbrss/- = 16.  
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G. Intracellular TCRβ staining in DN cells (DN = CD8- Gr-1- since CD4 expression is 
inappropriately unregulated in Cbfbrss/- DN cells 13,72) following six and nine days of 
OP9-DL1 culture. Cbfb+/+ = 4; Cbfbrss/- = 3. 
 
Figure 2. T cell specification fails to occur in Cbfbrss/- cells. 
A.  Lin- FL cells co-cultured on OP9-DL1 in the presence of Flt3L and IL-7 for seven 
days. CD8- Gr1- GFP- cells (GFP gating was used to eliminate OP9-DL1) were analyzed 
for CD44 and CD25 expression.  
B. Percentages of DN1, DN2, and DN3 cells (from A) averaged from 12 
independent experiments. Error bars represent SEM. The difference between the 
percentages of Cbfb+/+ and Cbfbrss/- cells was significant (*) at P ≤ 0.01. 
C. CD45+ Lin- (Lin = CD8, CD3, TCRβ, TCRγ, CD11c, B220, Mac1, NK1.1, Ter119) 
17.5 dpc fetal thymocytes analyzed for CD44 and CD25 expression.  
D. Data from 6 animals of each genotype (from C). The difference between the 
percentages of Cbfb+/+ and Cbfbrss/- cells was significant (*) at P ≤ 0.03. 
 E. Expression of cell surface Thy1.2 on 17.5 dpc DN1 (Lin-CD45+CD44+CD25-) 
thymocytes, and on DN1 cells (CD8- Gr-1-CD45+CD44+CD25-) from day 6 OP9-DL1 
cultures. The thymocyte data were averaged from 4 Cbfb+/+ and 4 Cbfbrss/- fetuses, and 
the culture data from 4 Cbfb+/+ and 3 Cbfbrss/- fetuses. Asterisks indicate significant 
differences between Cbfb+/+ and Cbfbrss/- samples (P = 0.01). 
F. Percentage of 17.5 dpc DN thymocytes (CD45+ Lin-, Lin=CD8, CD3, CD11c, 
B220, Mac-1, Ter119) expressing intracellular TCRβ (iTCRβ) and iTCRγ. Data are 
averaged from 3 Cbfb+/+ and 3 Cbfbrss/- fetuses.  
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G. Percentage of Thy1.2+ DN2 cells following 7 days of OP9-DL1 culture. 
H. Cd3e and Cd3g expression by qRT-PCR in DN2 cells sorted from day 7 OP9-
DL1 cultures (culture conditions and staining as described in A). The purity of post-sort 
populations was > 95%. Expression of individual genes was normalized to Hprt. Data 
were derived from triplicate amplifications from three independent samples. Asterisks 
indicate significant differences between Cbfb+/+ versus Cbfbrss/- values (P ≤ 0.01).  
I. Lin- FL cells cultured on OP9-DL1 cells, harvested at indicated time points. DN1 
cells (Lin- CD45+ CD44+ CD25-) were isolated by cell sorting (purity > 95%). The 
expression of individual genes was normalized to Hprt (note log scale for Tcf7) and 
displayed as relative to day 0 values of Cbfb+/+ DN1 cells. Values are averaged from 
triplicate samples isolated from three independent experiments. Asterisks indicate 
significant differences between Cbfb+/+ versus Cbfbrss/- values (P ≤ 0.05). 
J. Rescue of T cell development with CBFβ  in 17.5 dpc Cbfbrss/- FL cells. Lin- FL 
cells (E17.5) were transduced with the indicated retroviruses and co-cultured on OP9-
DL1. Cells were harvested after two weeks and GFP+ CD45+ cells analyzed for CD4 
and CD8 expression (top panels) and TCRγ expression (middle panels). The bottom two 
plots are DN cells analyzed after one week of co-culture. Gated GFP+ Lin- CD45+ cells 
were analyzed for expression of CD44 and CD25 (nexperiments=11).  
K.  Western blot showing CBFβ(p22) protein levels resulting from retroviral 
expression relative to endogenous protein levels, in whole cell extracts prepared from 
GFP+ CD45+ cells purified from the OP9-DL1 cultures of Lin- FL cells (CD45+ cell purity 
≥ 99.9%). The blot was probed with a monoclonal antibody to CBFβ. The two 
endogenous CBFβ isoforms generated as a result of alternative splicing (p21.5 and 
 35
 only.
For personal use at CALIFORNIA INST TECH/MILLIKAN LIBRARY on April 5, 2008. www.bloodjournal.orgFrom 
                                 
p22) are both visible on this gel. Samples were normalized for actin expression, and the 
relative amounts of CBFβ determined from a dilution series (not shown). CBFβ levels in 
retrovirally-transduced cells were 5-fold higher than endogenous levels. Lanes: 1, 
Cbfbrss/- + MigR1; 2, Cbfbrss/- + CBFβ; 3, Cbfb+/+ + MigR1; 4, Cbfb+/+ + CBFβ 
L. Inefficient rescue of T cell development upon restoring CBFβ expression in 17.5 
dpc Cbfbrss/- thymocytes. Thymocytes were transduced with the indicated retroviruses 
and co-cultured for 7 days on OP9-DL1. Gated GFP+CD45+ cells were analyzed for 
CD4 and CD8 expression in the plots below.  GFP+CD45- cells are predominantly OP9-
DL1 cells 16. 
M. Cell cycle status of CD45+ Lin- (Lin=CD8, TCRβ, TCRγ, CD11b, Ter119, B220) 
17.5 dpc fetal thymocytes.  
N. Summary of cell cycle data from 5 individual samples per genotype. The 
differences between Cbfb+/+ and Cbfbrss/- cells in G0/G1 and G2/M were significant at P 
≤  0.01.  
 
 
Figure 3. JAK/STAT and c-kit signaling in Cbfbrss/- T cells. 
A. Expression of IL-7Rα (CD127) and γc (IL2RG/CD132) on the DN2 thymocytes 
from Figure 2C (17.5 dpc). Data are representative of four experiments.  
B.  DN2 cells were sorted from OP9-DL1 cultures (culture conditions and staining as 
described in Figure 2A). The purity of post-sort populations was > 95%. Expression of 
individual genes was normalized to Hprt. Values are averaged from triplicate samples 
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from three independent experiments. Asterisks indicate significant differences (P ≤ 
0.05). 
C. pStat5 levels in 17.5 dpc DN2 thymocytes upon ex vivo stimulation with 0, 1 and 
5 ng/ml IL-7 for 20 minutes. Shown is the MFI of the difference between pStat5 under 
IL-7 stimulated and non-stimulated conditions. The data are averaged from 5 Cbfb+/+ 
and 5 Cbfbrss/- fetuses. Differences are significant at P<0.0001. 
D. Rescue of T cell development from Cbfbrss/- Lin- FL cells with CBFβ, but not wild 
type or constitutively active Stat5a (S711F; Stat5aF), or MigR1 alone (-) (n=5). Cells 
were harvested after two weeks. The expansion of Cbfbrss/- cells (left graph) is 
calculated by dividing the number of GFP+ cells on day 14 by that on day 7 of culture. 
Only CBFβ expression significantly (*, P ≤ 0.0001) increased cell numbers compared to 
MigR1-transduced Cbfbrss/- cells. The right hand graph shows the percentage of GFP+ 
cells expressing CD4 and CD8. 
E. Expression of cell surface c-kit on 17.5 dpc DN1 cells. Bar graph on left is the 
percentage of c-kit+ DN1 (Lin- as in Fig 2B; CD45+CD44+CD25-) thymocytes, and on 
right is the MFI of c-kit staining on c-kit+ DN1 thymocytes. The data are averaged from 4 
Cbfb+/+ and 4 Cbfbrss/- fetuses.  
F. Percentage of DN1 (CD44+ CD25- CD45+ Lin-) cells expressing surface c-kit and 
MFI of c-kit staining on c-kit+ DN1 cells after six days of OP9-DL1 culture. The data are 
averaged from 4 Cbfb+/+ and 3 Cbfbrss/- fetuses. 
 
Figure 4. Notch signaling is active in Cbfbrss/- cells and NK cell development is defective. 
 37
 only.
For personal use at CALIFORNIA INST TECH/MILLIKAN LIBRARY on April 5, 2008. www.bloodjournal.orgFrom 
                                 
A.  Lin- FL cells cultured on OP9-DL1 cells, harvested at indicated time points and 
stained with antibodies as described in Figure 2A. DN1 cells (Lin- CD45+ CD44+ CD25-) 
were isolated by cell sorting (purity > 95%). The expression of individual genes was 
normalized to Hprt (note log scale for Dxt1) and displayed as relative to day 0 Cbfb+/+ 
DN1 cells. Values are averaged from 9 samples (triplicate samples from three 
independent experiments). Asterisks indicate significant differences between Cbfb+/+ 
versus Cbfbrss/- values (P ≤ 0.05). 
B.  Flow cytometric analysis of Lin- FL cells cultured on OP9-DL1 (+Flt3L, IL-7, IL-6, 
IL-15) in the absence and presence of the gamma secretase inhibitor (GSI) inhibitor X 
for 7 days. GFP- CD45+ cells were analyzed for expression of NK1.1 (NK cells) and 
CD19 (B cells). nexperiments = 7.  
C. Lin- Cbfb+/+ 14.5 dpc FL cells transduced with either MigR1 or a retrovirus 
expressing the Notch1 intracellular domain (ICN) and cultured for 7 days on OP9 
stromal cells in the presence of Flt3L and IL-7. CD8- CD19- Gr1- cells were gated for 
GFP expression in the left hand panels, and GFP+ cells analyzed for CD44 and CD25 
expression in the right hand panels. 
D. Lin- Cbfbrss/- FL cells transduced with MigR1 or ICN, and analyzed as in panel C. 
 
Figure 5.  Inhibition of Notch signaling does not affect Runx1, Runx3, or Cbfb 
expression. 
A. Flow cytometric analysis of Lin- FL cells cultured on OP9-DL1 in the absence and 
presence of the indicated concentrations of GSI for 7 days. CD8- CD19- Gr1- GFP- cells 
were analyzed for CD44 and CD25 expression (nexperiments = 8). 
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B. Gene expression profile of DN1 cells sorted from day 7 OP9-DL1 co-cultures 
treated with DMSO (white bars), 1.0 μM GSI (gray bars), or 3.0 μM GSI (black bars). 
Cell sorting, RNA preparation, and real-time PCR were performed as described in 
Figure 4A. Taqman probes were used for the quantification of Runx1, Runx3, Cbfb and 
Hprt, and SYBR green was used for the remainder of the genes. Expression of each 
gene was quantified in comparison to a standard curve prepared with dilutions of spleen 
cDNA. The expression of individual genes is displayed relative to Hprt. Data are 
averaged from four independent experiments. Error bars represent SEM and asterisks 
indicate significant differences between GSI treated and untreated cells (P ≤ 0.05).  
C. Runx1 expression in lymphoid progenitors (c-kit+CD27+CD25-) isolated from day 
3 OP9-DL1 cultures in the absence and presence of 3 μM GSI (averaged from triplicate 
samples from three independent experiments). The increase in Runx1 expression in 
GSI-treated cultures was significant at P < 0.01. 
D. Ectopic expression of Runx1 in Cbfb+/+ FL cells cultured on OP9-DL1 in the 
absence and presence of GSI at 3 μM. Analysis was performed as in panel A. 
 
Figure 6. CBFβ is required at an early stage of NK cell development in vivo. 
A. Representative scatter plots of Lin- 15.5 dpc FL cells grown on OP9 cells in the 
presence of Flt3L, IL-7, and IL-15. Gr-1-CD19- cells were analyzed for CD122 and 
NK1.1 expression.  
B. Percentage and absolute number of CD122+ cells (±SD) harvested from OP9 
cultures established from 3 Cbfb+/+ and 4 Cbfbrss/- fetuses (nexperiments = 3). 
C. NK cells in 15.5 dpc fetal thymuses.  
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D. Total number of thymic NK1.1+ and NK1.1+ CD122+ cells averaged from 3 Cbfb+/+ 
and 3 Cbfbrss/- fetuses (nexperiments = 3). 
 
E-G.  Lethally irradiated CD45.1 x CD45.2 F1 recipients were reconstituted with wild-
type CD45.1+ bone marrow and CD45.2+ FL cells from Cbfb+/+, Cbfbrss/rss or Cbfbrss/- 
fetuses (expressing 100%, 30% and 15% of normal CBFβ levels, respectively).  
E.  Bone marrow of recipient mice analyzed 10 months after reconstitution. The data 
are from gated FL-derived (CD45.2+) progenitors. A representative example is shown in 
each group (Cbfb+/+, n=4; Cbfbrss/rss, n=4; Cbfbrss/-, n=5). Bone marrow from a 10 week 
old C57BL/6 (B6) mouse is shown as control. CD19-CD3-TCRβ-NK1.1+DX5+ cells are 
mature NK cells, while immature NK lineage cells (iNK) have a NK1.1+Dx5- phenotype.  
F.  The spleen of recipient mice analyzed in a similar way, illustrating the absence of 
immature and mature NK cells among cells derived from Cbfbrss/- progenitors.  
G.  Primitive NK lineage committed progenitors (NKP) (CD122/IL2Rβ+ NKG2D+ 
NK1.1- Dx5- LinT-) (LinT = CD3 CD4 CD8α TCRβ TCRγ) are preserved in the spleen of 
recipient mice. NKP express the IL-2/IL-15Rβ chain and have an NK1.1-Dx5- CD19-
CD3-CD4-CD8a-TCRβ-TCRγ- phenotype. A fraction of these cells expresses NKG2D 3.  
H. Expression Runx1, Runx3, and Cbfb by qRT-PCR in LSK (Lin=CD4, CD8, TCRβ, 
TCRγ, DX5, CD19, Mac-1, Ter119), iNK (CD4- CD8- TCRβ- TCRγ- CD19- CD49b- 
NK1.1+ CD122+) and mature NK (CD4- CD8- TCRβ- TCRγ- CD19- CD49b+ NK1.1+ 
CD122+) cells sorted from bone marrow of 8 – 12 week old wild type mice. The purity of 
post-sort populations was > 98%. Expression of individual genes was normalized to 
Hprt. Asterisks indicate significant differences from LSK cell values (P ≤ 0.01). 
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Figure 7. Genetic interactions between the CBFs and Notch signaling in the 
specification of HSCs, T, and NK cells in the fetus.  
Notch receptors and ligands are expressed on the aortic endothelial cells in the 
AGM region that give rise to HSCs 20. Notch signaling is required for Runx1 expression 
in endothelial cells and for the formation of HSCs 19,20,23,24, and thus Notch is genetically 
upstream of Runx1 in HSC formation. (Solid lines indicate molecular interactions, and 
dashed lines represent cell migrations. PB, peripheral blood.) 
HSCs and progenitors are released into the circulation from their sites of 
formation and colonize the fetal liver. We speculate that Runx1 and/or Runx3 plus CBFβ 
are required to generate NKP from either a bipotent T/NK or another progenitor in the 
fetus, and perhaps in T/NK progenitors themselves. CBFs are also required for the NKP 
to iNK transition, based on data from the adult.  
Circulating progenitors expressing all three CBF complexes colonize the thymus 
where they encounter high levels of Notch ligands. CBFs confer upon these progenitors 
the ability to respond to Notch signaling, which results in T cell specification and 
progression to the ETP/DN2 stage accompanied by the expression of a suite of T cell 
specific genes. Not shown are NKT cells, which differentiate from DP T cells in a 
Runx1-dependent manner.  
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